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Abstract
BIOBEHAVIORAL MECHANISMS OF EMOTION AND HIV DISEASE: EXPLORING
POTENTIAL MEDIATORS OF THE RELATION BETWEEN TRAIT POSITIVE AND
NEGATIVE AFFECT AND HIV HEALTH STATUS

By: Karen Elaine Stewart
Master of Science
Mississippi State University
2002

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University

Virginia Commonwealth University, 2010.
Major Director: Kirk Warren Brown, Ph.D.
Assistant Professor
Department of Psychology

Considerable research supports an association between negative psychosocial functioning
and adverse health outcomes. The biobehavioral model is well supported and posits that
these effects occur via alterations in physiological response and health damaging behaviors.
Evidence is accumulating about potential benefits of positive psychosocial functioning;
however, less is known about the mechanisms of these effects. The broaden-and-build
model of positive emotions holds that positive emotions can undo the physiological and
behavioral restrictions associated with negative emotions and promote resource development.
The present correlational study sought to explore whether cortisol, medication adherence,

and health behaviors (smoking, alcohol use, physical activity, and nutrition) mediated
relations between trait positive affect and negative affect and health status in persons living
with HIV infection. A moderating role of trait positive affect on the relation between
negative affect and mediating variables was also hypothesized, yet an unexpectedly high
correlation between trait positive and negative affect precluded the evaluation of this
hypothesis. HIV-infected participants (N = 53) collected salivary cortisol five times over the
course of one day at home and completed interview the following day. Clinical staff
provided HIV symptom ratings, and virologic and immunologic indicators were collected by
chart review. Results showed that high trait positive affect was associated with lower total
cortisol concentration, and total cortisol mediated the relation between trait positive affect
and CD4+ percent. High trait negative affect was associated with poorer medication
adherence, and percent adherence mediated the relation between trait negative affect and
CD4+ percent and viral load. Mediation hypotheses for health behaviors were not
confirmed. Trait positive affect was, however, associated with decreased alcohol intake,
increased physical activity, and better nutrition habits. Because this study used crosssectional design, causation cannot be determined. However, findings provide preliminary
evidence on mechanisms by which trait positive affect could be related to HIV disease
markers, and findings support existing evidence on mechanisms of trait negative affect in
HIV disease. Results also support use of the biobehavioral model and the broaden-and-build
model of positive emotions as theoretical frameworks in studying the relation between
psychosocial functioning and health outcomes in persons with HIV.

Biobehavioral Mechanisms of Emotion and HIV Disease: Exploring Potential Mediators of
the Relation Between Trait Positive and Negative Affect and HIV Health Status

Over 18,000 persons died from HIV disease in the U.S. in 2003, and over 1 million were
living with the disease. The introduction of highly active anti-retroviral treatments
(HAART) in 1996 has dramatically reduced the rate at which persons with HIV disease
progress to AIDS, resulting in longer life and better quality of life (CDC, 2004). In fact,
these medications have changed the nature of HIV disease such that it has come to be
considered a chronic, rather than terminal illness, and patients with HIV disease are living
long enough that they are increasingly dying from non HIV-related illnesses (Krentz,
Kliewer, & Gil, 2005). Thus, comprehensive care for a patient with HIV disease focuses not
only on HIV disease management but also on lifestyle factors intended to promote general
health and to enhance quality of life.
A number of aspects of psychosocial functioning, including mood disorders, trait
affect, and dispositional coping and cognitive styles have been shown to impact morbidity
and mortality in both healthy and chronic illness populations (e.g., Barger & Sydemann,
2005, Danner, Snowden, & Friesen, 2001, Leserman, Petitto, Gu, Gaynes, Barroso, &
Golden, 2002; Moskowitz, 2003). Existing research has focused primarily on the negative
side of psychosocial adjustment, and more recent attention has turned towards studying
potential benefits of positive psychological functioning. A number of studies have focused
on the benefits of positive dispositional factors such as optimism, benefit finding, and
mindfulness; however, fewer studies have focused specifically on trait emotional experience.
The current study sought to utilize theory specific to biological and behavioral mechanisms
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of positive emotions in exploring the relation between the tendency to experience positive
and negative emotions over time, neuroendocrine responding, health promoting behaviors,
and health status in persons living with HIV disease.
Two theoretical models will be employed in the current study. The biobehavioral
model holds that psychological factors generally impact health through biological
mechanisms (e.g. neuroendocrine, cardiovascular, and immune changes) and behavioral
mechanisms (e.g. adherence to medical recommendations, substance use, diet, smoking, and
physical activity levels) (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002; Williams,
Barefoot, & Schneiderman., 2003). This model has been well-supported in describing
mechanisms of negative psychosocial functioning in that depression, anxiety, and hostility
have each been linked to alterations in either neuroendocrine, cardiovascular, or immune
responding (Fredrickson, Mancuso, Branigan, & Tugade, 2000; Polk, Cohen, Doyle, Skoner,
& Kirschbaum, 2005; Suarez, Kuhn, Schanberg, Williams, & Zimmerman, 1998; Van Eck,
Berkhof, Nicolson, Sulon, 1996) and depression is linked to poorer health behaviors (Kobau,
Safran, Zarck, Moriarty, & Chapman, 2004; Yarcheski, Mahon, Yarcheski, & Cannella,
2004) and poorer adherence to medical recommendations (DiMatteo, Lepper, & Croghan,
2000). Far fewer studies have examined potential mechanisms of positive psychosocial
functioning. Fredrickson’s broaden-and-build model specifically posits that positive
emotions have the potential to promote positive changes in these biological and behavioral
mechanisms in that positive emotions undo the restrictions associated with negative
emotions. This undoing involves a reduction in physiological arousal and a broadening of
one’s attention, thinking, and behavioral repertoires. Further, the broaden-and-build theory
holds that positive emotions enhance the development of physical, social, psychological, and
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intellectual resources, which contribute to an increased experience of positive emotions and
further resource development in what Fredrickson calls the upward spiral of positive
emotions (Fredrickson, 2000).
Taken together, these two theories provide a framework for exploring the potential
benefits of frequent experience of positive emotions in persons living with HIV disease.
Specifically, positive emotions may be associated with enhancements of physical functioning
(e.g. healthier neuroendocrine functioning) and with positive health behavior profiles (e.g.
greater physical activity, better medication adherence, healthier eating habits, and lower rates
of substance use, smoking, and risky sexual behavior) that may over time lead to better
health outcomes if they occur on a frequent basis. The primary goal of the current study was
to clarify the relation between trait experience of positive and negative emotions and health
in persons with HIV disease and to evaluate whether positive emotions might relate to health
via similar mechanisms as negative emotions. This study also sought to establish whether
positive emotions relate to neuroendocrine responding, health behavior, and health status
independent of negative emotions or by buffering the deleterious effects of negative
emotions. Because the impact of emotions on health in persons with chronic illness is likely
to be a result of chronic rather than momentary behavioral practices and neuroendocrine
processes (Herbert & Cohen, 1993, Pressman & Cohen 2005), the current study will focus on
the effects of trait, rather than state, emotions. Although clinical distinctions between the
terms affect and emotion are well-defined, these terms are used inconsistently in the research
literature, thus, they will be used interchangeably throughout this paper.
The Biobehavioral Model
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In 1975, Rosenman, Brand, Jenkins, Friedman, Straus, and Wurm published a
landmark study in the Journal of the American Medical Association linking Type A behavior
pattern (time urgency, hostility, and achievement orientation) to increased incidence of
coronary heart disease (CHD) during an 8.5 year follow up period. In another pivotal study
using a sample of 99 generally healthy men, Peterson, Seligman, and Vaillant (1988) showed
that explanatory style during early adulthood (age 25) predicted health outcomes during
middle age (ages 45-60), even after controlling for baseline physical and mental health. Men
with a pessimistic explanatory style began to experience significantly greater health problems
at age 45 compared to more optimistic individuals. These studies helped set the stage for
deeper investigation into the specific psychosocial factors that relate to adverse health
outcomes and the biological and behavioral mechanisms by which these effects occur.
Negative psychosocial functioning impacts health. In addition to the effects of
hostility and pessimism described above, wide ranging aspects of negative psychosocial
functioning have been linked to adverse health outcomes. For example, depression increases
risk of onset of coronary heart disease (CHD; Wuslin & Singal, 2003) and predicts morbidity
and mortality among patients with existing CHD (Barefoot & Schroll, 1996). Depression is
an independent risk factor for type 2 diabetes mellitus (Eaton, Armenian, Gallo, Pratt, &
Ford, 1996), and although the role of depression in onset of cancer is of marginal
significance (McGee, Williams, & Elwood, 1994), persons with a lifetime history of
depression have been shown to have a 2.6 times greater risk of dying of cancer than persons
without a history of depression (Stommel, Given & Given, 2002). Anxiety is an independent
risk factor for all-cause mortality in both men and women (Eaker, Sullivan, Kelly-Hayes,
D’Agostin, & Benjamin, 2005), increases chances of developing CHD (Barger & Sydemann,
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2005), and increases risk of death and recurrent ischemic events following acute coronary
events (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002). Thus, negative psychological
dispositions and clinical syndromes associated with frequent negative emotions appear to
negatively impact health in specific populations, and health psychologists have investigated
both biological and behavioral mechanisms to help explain these relations.
Negative psychosocial functioning impacts biological mechanisms. Negative
emotions stimulate activation of the sympathetic nervous system (SNS) and the
hypothalamic-pituitary-adrenocortical (HPA) axes. Activation of the SNS causes increases in
heart rate, blood pressure, and respiration, as well as increased blood flow to muscles.
Activation of the HPA axis stimulates the release of corticosteroids such as cortisol, which
serve to increase blood glucose to provide energy and to suppress antibody production,
thereby mediating inflammation. These two systems developed through adaptation and serve
the function of optimizing response to a threatening situation (Friedman, 2002). It is
adaptive for these responses to occur in order to effectively respond to survival demands of
the environment; however, when they occur on a chronic basis, these responses can over time
result in adverse health outcomes. For example, cortisol suppression of antibody production
may represent a useful diversion of resources towards immediate rather than long-term
survival in the context of an acute stressor; however, with chronic HPA stimulation,
resistance to infection may be compromised (Friedman 2002). Thus, while momentary
emotional experiences elicit immediate physiological responses, it is likely that the chronicity
of these emotional experiences will be the determining factor in whether emotions will
demonstrate an impact on health outcomes (Herbert & Cohen, 1993). Elevated cortisol
levels have been associated with measures of depression and trait anxiety (Van Eck et al.,
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1996); however, the relation between cortisol and depression is complicated. For example,
cortisol levels can remain elevated in some individuals well past the remission of depressive
symptoms (Cowen, 2010). These individuals often are at higher risk of recurrence of
depressive symptoms. Elevated cortisol levels have also been identified in people with no
personal history of depression but who are at elevated risk of depression due to family
history or high neuroticism scores. These findings suggest that a cyclical relation between
cortisol and depression exists, such that cortisol hypersecretion, which may be at least partly
genetically determined, elevates risk of depression and that depressive episodes are
associated with increased secretion of cortisol; this may or may not remit along with
depressive symptoms. The current study contributes to a segment of the research literature
that focuses on the portion of this cycle whereby psychological functioning influences health
via neuroendocrine and behavioral responding; however, it is important to recognize that this
is not a simple unidirectional relation.
There is evidence that this pattern of physiological arousal associated with negative
psychological functioning may partially explain the observed effects on health outcomes. For
example, the effects of the Type A behavior pattern on coronary heart disease were found to
be most closely explained by to the component of hostility (Williams et al., 1980), and this
has been related to increased magnitude and duration of physiological responses (blood
pressure, heart rate, and cortisol secretion) to experimentally induced stressors (Fredrickson
et al., 2000; Suarez et al., 1998). The relation between depression and CHD may be due to
increased physiological risk factors (vascular pathology, ventricular tachycardia, and
decreased heart rate variability) associated with depression (Evans et al, 2005). Depression
exacerbates complications of diabetes through poor glycemic control and increased insulin
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resistance, which may be a result of increased serum glucocorticoids (Evans et al., 2005), and
the relation between cancer mortality and depression may be mediated by the
immunosuppressive effects of depression (Spiegel & Giese-Davis, 2003).
While most studies have focused on the momentary (state) relation between negative
affect and cortisol, a few studies have examined the relation between trait negative affect and
total cortisol concentration. Elevated cortisol levels have been associated with high trait
negative affect in one study (Polk, et al., 2005) but not in another (Hanson, Maas, Meijman,
& Godaert, 2000). The inconsistency between these two studies may be explained by the use
of different conceptualizations and measurements of emotion. Polk et al. (2005) assessed
trait positive and negative emotions using an adjective rating scale (Usala & Hertzog, 1989)
three times per week over the course of two weeks. Positive adjectives included lively, fullof-pep, energetic, happy, pleased, cheerful, at ease, calm, and relaxed. Negative adjectives
included sad, depressed, unhappy, on edge, nervous, tense, hostile, resentful, and angry.
Trait positive and negative affect were calculated by summing results across the six
measurements over the two week period. Hanson et al. (2000) developed an index of trait
negative affect using items from a Dutch translation of the Well-being Questionnaire
(Bradley & Lewis, 1990) which were originally designed to assess symptoms of anxiety and
depression in persons with diabetes. Participants were asked to rate how often each
statement described how they felt during the past few weeks on a 4-point Likert scale from
not at all to all the time. Sample statements included “I have crying spells or feel like it” and
“I feel nervous or anxious” (Hanson et al., 2000). These reported inconsistencies in the
relation between trait negative affect and cortisol responding may be a result of
inconsistencies in defining and measuring trait negative affect and a consensus has not yet
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been reached about the best method for measuring trait negative affect in studies of diurnal
cortisol.
Negative psychosocial functioning impacts behavioral mechanisms. In a sample
of 166,564 community participants, increasing numbers of “sad, blue, or depressed” days per
month were related to smoking, extremely high and low body mass index (BMI), higher rates
of binge drinking, and lower rates of physical activity (Kobau et al., 2004). Meta-analyses
have shown that depression increases risk of non-adherence with medical treatment
(DiMatteo, Lepper, & Croghan, 2000) and decreases the likelihood of engaging in such
positive health practices as physical activity and relaxation (Yarcheski, Mahon, Yarcheski, &
Cannella, 2004). Persons who are depressed have double the smoking rates of non-depressed
controls and are less likely to quit smoking (Brandon, 1994). Hostility in healthy adults aged
18-30 and pessimistic explanatory style in college students have also been linked to poorer
health behaviors, including increased rates of smoking cigarettes and marijuana, increased
caloric intake, and greater alcohol consumption (Peterson, 1988; Scherwitz, Perkins,
Chesrtey, Hughes, Sidney, & Manolio, 1992). Thus, negative emotions appear to be
associated with unhealthy behaviors in some cases.
The Broaden-and-Build Model of Positive Emotions
Negative emotions are ancestrally linked to potentially threatening situations that
elicit distinct drives for survival. These drives result in the diversion of cognitive and
physical resources toward preparing to react to the threat situation. This then results in
restricted physiological and psychological responding in ways that can be harmful to health.
Because positive emotions are not related to imminent threat, they do not require a prescribed
immediate call to action, as do negative emotions, and thus positive emotions can result in

8

greater flexibility of physiological and behavioral response (Fredrickson, 2000). Studies
have demonstrated that both state and trait positive emotions have the potential to impact
biological mechanisms by undoing the effects of negative emotions. For example, after
watching a frightening film, participants who were shown videos of puppies or waves
crashing on a beach showed faster return of heart rate to baseline than those who were shown
either sad or abstract films following the frightening film. This supports the role of state
positive affect in undoing the effects of state negative affect. In the same study, a faster
recovery was also noted for participants who smiled spontaneously during the frightening
film, suggesting a possible protective role of trait positive affect in the presence of state
negative affect (Fredrickson & Levenson, 1998). The cumulative effect over time of
improved cardiovascular recovery experienced by those high in trait positive affect could
translate into lower risk of cardiovascular disease due to decreased strain on the heart (Kok,
Catalino, & Fredrickson, 2008).
While negative emotions are typically associated with avoidance behavior, positive
emotions are associated with approach behaviors (Fazio, Eiser, & Shook, 2004). Positive
emotions are also associated with greater creativity, cognitive flexibility, openness to new
information, and enhanced problem solving skills that could impact behavioral responding.
Isen, Daubman, and Nowicki (1987) believe that people undergo a cognitive reorganization
when they are experiencing positive affect such that it is easier for them to generate unique
and new associations that allow for greater generation of ideas for problem solving. In a
problem solving study involving a matchbox, a thumbtack, a corkboard, and a candle, 75% of
participants who watched a brief positive mood inducing video prior to the task generated the
correct solution. Only 20% of participants in the neutral film condition and 13% in the
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negative film condition correctly solved the problem (Isen et al., 1987). Fredrickson (2000)
describes this expanded and open psychological state as a broadened momentary thoughtaction repertoire, which enlarges a person’s cognitive-behavioral context in ways that lead to
the development of lasting physiological, psychological, intellectual, and social resources.
Over time, these enhancements in personal resources lead to increases in positive emotions
which lead to further resource development and so forth, in what Fredrickson calls the
upward spiral of positive emotions. In support of the upward spiral hypothesis, prospective
studies have demonstrated that positive emotions predict positive coping which in turn
predict future positive emotions (Burns, Brown, Sachs-Ericsson, Plant, Curtis, Fredrickson,
& Joiner, 2008; Fredrickson & Joiner, 2002). In their prospective analysis examining the
upward spiral of coping and social resources, Burns et al. (2008) found that both
interpersonal trust and positive coping (defined as “approach” coping as opposed to
“avoidance/resignation coping”) partially mediated enhancements in positive emotions over
time and that positive emotions partially mediated enhancements in interpersonal trust and
positive coping over time.
These positive emotion-associated enhancements in problem solving, interpersonal
trust, and approach based coping skills could include skill development in the domain of
health promoting behavior. Ingledew and McDonagh (1998) found that health behaviors
such as exercise and self-care can serve coping functions. It is possible that the development
of coping resources in this upward spiral will include using positive health behaviors,
particularly for individuals with medical conditions who may choose to use healthy behaviors
as an approach based coping response to their concerns for their physical well-being.
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In summary, the broaden-and-build model of positive emotions puts forth two types
of effects of positive emotions. The upward spiral theory suggests that enhancements in
physical, social, intellectual and psychological functioning serve as potential mediators of the
relation between trait positive affect and health. The undoing theory proposes that positive
emotions exert their effects by reducing physiological and psychological restrictions
associated with negative emotions. This study sought to examine hypotheses consistent with
both the upward spiral and undoing theories of positive emotions.
Positive psychosocial functioning impacts health. Emerging evidence suggests an
association between positive psychological functioning and reduced morbidity and mortality
in both healthy and specific illness populations, although inconsistencies have been reported
in studies of cancer mortality. In a study of 180 Catholic nuns, positive emotional content in
autobiographical statements collected at around age 22 predicted survival at ages 75-99.
Nuns whose positive affect scores were in the lowest quartile were 2.5 times more likely to
have died at follow-up than those whose scores were in the highest quartile (Danner,
Snowden, & Friesen, 2001). Life satisfaction was found to predict mortality among men, but
not women, over a 20-year follow-up period in a Finnish sample of 18-64 year olds.
Specifically, men with low life satisfaction in the sample were at higher risk of disease
mortality, and this effect was especially pronounced among men who reported heavy levels
of alcohol use at baseline, suggesting a possible mediating role of adverse health behavior
(Koivumaa-Honkanen, Honkanen, Viinamaki, Heikkila, Kaprio, & Koskenvuo, 2000).
Notable exceptions to the literature on mortality and positive affect include two studies that
demonstrated an association between positive affect and shorter survival in persons with
metastatic breast cancer (Derogatis, Abeloff, & Melisaratos, 1979) and early stage melanoma
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(Brown, Butow, Culjak, Coates, & Dunn, 2000). However, a recent meta-analysis including
70 studies on positive affect and positive psychological traits demonstrated that trait positive
affect was associated with reduced all-cause mortality in healthy populations (Chida &
Steptoe, 2008). Further, positive psychological traits (such as optimism and hopefulness)
were associated with reduced mortality in patients with renal disease and HIV disease. The
analyses in this meta-analysis took publication bias and potential behavioral correlates of
positive emotions into account.
Morbidity studies have also shown relations between positive emotions and reduced
illness across diverse medical conditions. Trait positive emotions, or sometimes called
“positive emotionality,” has been associated with decreased prospective risk of stroke (Ostir,
Markides, Peek, & Goodwin 2001), reduced rates of all-cause rehospitalization for patients
with cardiovascular disease (Middleton & Byrd, 1996), and reduced risk of developing cold
symptoms following exposure to cold virus (Cohen, Doyle, Turner, Alper, & Skoner, 2003).
Thus, although positive affect has demonstrated some conflicting findings in cancer
populations, positive affect and positive psychological functioning appear to be associated
with reduced mortality and morbidity in healthy and specific chronic illness populations.
Positive psychosocial functioning impacts biological mechanisms. Although
experimental manipulations of positive emotion often fail to show a consistent relation
between state positive emotions and momentary cortisol response, when measured over a
more lengthy time period, the tendency to experience positive emotions appears related to
lower levels of cortisol in healthy individuals (Pressman & Cohen, 2005). For example, in a
sample of 216 London civil servants (Steptoe, Wardle, & Marmot, 2005), ratings of
happiness measured over a two day period was related to lower cortisol levels such that the
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happiest quintile showed a 32.1% lower cortisol level compared to the least-happy quintile.
This effect was independent of psychological distress, and a similar effect was found in this
sample for ambulatory heart rate. Further, compared to the least-happy quintile, the happiest
quintile in this sample experienced a significantly lower increase of fibrinogen (a coagulant
protein) in response to an induced stress task. A follow-up study with this sample (Steptoe &
Wardle 2005) revealed that the association between positive emotions, cortisol, and heart rate
was maintained over a period of 3 years. This 3-year follow-up also revealed an additional
health benefit of happiness such that systolic blood pressure was lower among the happiest
participants. Thus, trait positive emotions may be associated with reduced cortisol secretion
and other reductions in physiological arousal.
Positive psychosocial functioning impacts behavioral mechanisms. If it is true
that positive emotions contribute to the development of positive health behavior practices as
part of the development of coping resources, one might expect to find a relation between a
person’s tendency to experience positive emotions and to practice good health behaviors.
Only one published study located has explicitly examined the relation between the tendency
to experience positive emotions and health behaviors. Cohen et al. (2003) found that positive
emotional style was associated with better sleep quality, better sleep efficiency, increased
dietary zinc intake, and increased physical activity levels. Zinc deficiency is associated with
impairments in neuropsychological functioning and reduced immunity (Maret & Sandstead,
2006). A recent meta-analysis also demonstrated that hope and positive self-esteem were
related to a measure of "general health practices" defined by physical activity and relaxation
(Yarcheski, Mahon, Yarcheski, & Cannella, 2004). Feeling good about oneself may enhance
interest in protecting health and increase confidence to take action towards this goal. Self-
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affirmation through recall of acts of kindness has been shown to increase attention to healthrelevant information and subsequent ratings of personal control over changing behavior
(Reed, 1998). Thus, positive psychological well-being may be associated with better health
practices, although more studies are needed to confirm this relation, and research is needed to
address the specific role of positive emotions in facilitating positive health behaviors.
The Relation Between Positive and Negative Emotions
Intuitively, one might expect positive and negative emotions to be inversely related,
such that as positive emotions increase, negative emotions decrease and vice versa.
Empirically determining the relation between positive and negative emotions has proven to
be complicated. Initial studies focused on trait emotions asked participants to simply indicate
if they had experienced certain emotions during the last few weeks. Bradburn (1969;
Bradburn & Caplovitz, 1965) found that subscales of positive and negative emotions were
weakly correlated with one another, interitem correlations within subscales were high, and
positive and negative emotion subscales correlated differently with criterion variables. This
suggested that positive and negative emotions are relatively independent of one another.
However in a series of survey and experience-sampling studies, Diener and Emmons (1984)
found that the relation between positive and negative emotions depends on the time frame
measured, such that positive and negative emotions are inversely related when measuring
momentary (state) emotional experiences and are only weakly related when measuring longer
time frames (trait emotional experiences). This means that a person’s momentary experience
of positive emotions reduces his/her likelihood of experiencing negative emotions in that
same moment (and vice versa), but the tendency to experience positive emotions over a
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longer time frame (weeks to a year) is nearly unrelated to their tendency to experience
negative emotions during that same time frame (Diener & Emmons, 1984).
A number of additional considerations impact the observed relation between positive
and negative emotions. For example, the magnitude of the inverse relation between positive
and negative emotions is stronger when frequency rather than degree of emotional experience
is measured (Watson, Clark, & Tellegen, 1988). Semantic construction of emotion measures
can also contribute to the degree of independence between positive and negative emotions.
For example, happiness and sadness are semantically opposite emotional states. In contrast,
the terms “nervous” and “excited” also represent positive and negative emotional states, but
they are not semantic opposites. Therefore, a researcher can achieve independence or
bipolarity of positive and negative emotions by selecting the terms to use in a given measure
of emotion (Barrett & Russell, 1999). According to Barrett and Russell (1999), emotions
inhabit a two-dimensional space defined on one dimension as degree of pleasantness (versus
unpleasantness) and on the other dimension as degree of activation (arousal and energy). In
their theoretical model, happiness (moderate activation, pleasant) and sadness (moderate
activation, unpleasant) appear directly opposite one another, whereas nervousness (high
activation, unpleasant) and excitement (high activation, pleasant) appear on the same side of
the activation dimension of the affective space. Thus, the degree of independence of positive
and negative emotions depends on the combination of items used in a scale to define these
constructs.
In developing the Positive Affect Negative Affect Schedule (PANAS), Watson et al.
(1988) sought to develop a scale with independence of positive and negative emotions. They
selected items that on factor analysis showed high loadings for one factor and near-zero
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loadings on the other factor. As a result of this process, the PANAS includes items that are
all high on activation. Thus the positive and negative emotions assessed by the PANAS (e.g.
excited, distressed) are only slightly negatively correlated with one another. The instructions
for the PANAS vary across versions in terms of the time frame for which the participant is
requested to make their ratings, ranging from right now, that is in the present moment to in
general, that is on the average. Positive and negative emotions are most strongly correlated
when the during the past year instructions are used (r = -.23) and are least correlated when
the today instructions are used (r = -.12). The current study used the in the past few weeks
instructions, for which positive and negative emotions have been shown to correlate at r = .22 (Watson et al., 1988). This means that the PANAS is a desirable measurement tool in the
current proposal as the relative independence of positive and negative emotions allows for
exploration of a moderating hypothesis - specifically that the presence of trait positive
emotions will “buffer” against the effects of trait negative emotions on health outcomes in a
way that is consistent with Fredrickson’s undoing theory.
Summary
The biobehavioral model is based primarily on studies of negative psychosocial
functioning and suggests that psychosocial factors influence health through both biological
and behavioral mechanisms. The broaden-and-build model supports the possibility that
positive emotions impact health by undoing the ancestrally rooted biological and behavioral
restrictions associated with negative emotions, and will foster the development of physical,
social, psychological, and intellectual resources. Negative psychological functioning has
been linked to increased mortality and morbidity and impacts biological systems through
activation of the SNS and the HPA axes. This pattern of activation triggers neuroendocrine,
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cardiovascular, and immune changes that can be deleterious to health over time. Negative
emotions are also related to negative health behavior patterns in healthy adults. Conversely,
positive emotions, and dispositions associated with positive psychological functioning, have
been found to relate to greater survival in Catholic nuns and Finnish men and to reduced
morbidity with regard to lifetime risk of stroke, risk of rehospitalization in those with
cardiovascular disease, and risk of developing cold symptoms upon viral exposure.
Conflicting results have been noted in studies of positive emotions and cancer mortality
studies. Trait positive emotions have also been linked to reduced cortisol in healthy adults.
Positive emotional style has been found to relate to better sleep, increased zinc intake, and
greater physical activity levels. The current study seeks to clarify the relation between trait
positive affect and health in persons living with HIV disease and seeks to determine if
positive emotions relate to health via similar mechanisms as do negative emotions.
Applying the Biobehavioral and Broaden-and-Build Models to HIV Disease
Managing HIV disease requires an understanding of how the virus impacts its host.
As a retrovirus, HIV inserts itself into a cell and is incorporated into the host cell’s genetic
material (DNA). As the virus replicates, it causes a number of problematic changes in bodily
systems. The most damaging of these changes is that the virus compromises the immune
system, primarily by destroying CD4+ T-lymphocyte cells (USDHHS, 2004). Central to the
coordination of the immune system, CD4+ cells direct other immune cells to carry out their
specific functions. As CD4+ cell counts decrease, the immune system becomes increasingly
impaired (CDC, 1992). This increasing immune dysfunction is associated with numerous
symptoms such as decreased energy, increased pain, and insomnia (Solano, Gomes, &
Higginson, 2006), as well as vulnerability to infection and increased mortality (CDC, 1992).
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According to guidelines developed by the Centers for Disease Control and Prevention
(CDC), people are diagnosed with AIDS when they develop any AIDS-defining illnesses
(such as pneumocystis carinii pneumonia) and/or their CD4+ count is below 200 cells/µL
(CDC, 1993). As a supplement to CDC staging criteria, viral load (the number of detectable
copies of the virus in peripheral blood) is used as an indicator of disease severity and
effectiveness of medication regimens (Samet et al., 2003). CD4+ lymphocyte percent and
CD4+/CD8+ ratios also serve as indicators of immunological status. Of the immune
markers, CD4+ percent may be the best indicator because it has less measurement error and
may provide better prognostic value in estimating disease progression than the more
traditional CD4+ total cell count (Zeller, McCain, & Swanson, 1996). Thus, as HIV disease
progresses, people are at greater risk of adverse health outcomes.
Cortisol and HIV disease. Cortisol is a glucocorticoid hormone that follows a
diurnal circadian cycle characterized by a morning rise reaching peak levels approximately
30-45 minutes after waking followed by a continual decline throughout the waking hours
(Polk et al., 2005). Alterations in both total circulating levels and the circadian pattern of
cortisol (e.g. flattened curve, attenuated or exaggerated morning rise, elevated evening levels,
etc.) have been associated with poorer psychosocial functioning and health outcomes (Adam
& Kumari, 2009). HIV infection is associated with a shift in steroid metabolism, which
results in increased cortisol levels as well as decreased dehydroepiandrosterone (DHEA)
(Clerici et al., 2000). Persons with HIV disease at any stage may show elevated mean
cortisol levels compared to the normal population, and cortisol levels have been shown to
have an inverse relation with CD4+ counts (Christeff et al., 1997). In a study of 82
asymptomatic HIV-infected men, a 5 µg/dl increase of cortisol was associated with double
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the risk of developing AIDS (Leserman et al., 2000). In another study with 96 men, a 3 µg/dl
increase in average cumulative cortisol was associated with a 40% increased risk of
developing AIDS and a 2.6-fold increase in mortality (Leserman et al., 2002). Thus, cortisol
levels may be related to health status in HIV disease. However it remains uncertain whether
cortisol elevations directly impact the course of disease progression or rather reflect the
immune dysregulation that occurs as part of this progression.
Behavioral mechanisms and HIV disease. Medication adherence is critical to
treatment outcome in managing HIV disease. HAART medications exert their effects by
suppressing HIV virus replication, and treatment adherence over 95% is required for optimal
viral suppression. Patients with 90% or greater medication adherence showed a median of 89
weeks to viral failure compared to 42 weeks for those with 70-90% adherence and 30 weeks
for those with <70% adherence (Kitahata et al., 2004).
Health behaviors, including smoking, alcohol/drug use, physical activity level, diet,
and sexual risk behavior may impact HIV-related health outcomes, although findings remain
equivocal. Persons with HIV disease who smoke are at an increased risk for several HIVrelated infections, including hairy leukoplakia and oral candidiasis (Collins et al., 2001).
Smoking was associated with more rapid disease progression and higher risk of death in a
sample of 395 HIV-infected men (Page-Shafer, Delorenze, Satariano, & Winkelstein, 1996).
Among 924 HIV-infected women taking HAART, smokers were less adherent to their
medications; however, after controlling for adherence, smokers still had poorer viral
responses to their medication (Feldman et al., 2006). In vitro lab studies using human
macrophage cells have suggested that alcohol may directly compound the immune
suppressing effects of HIV (Chen, George, & Sperber, 1998, Wang et al., 2002), and alcohol
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abuse has been associated with reduced virulogic and immune response to HAART (Miguez
Shor-Posner, Morales, Rodriguez, & Burbano, 2003). However, poorer virulogic and
immune status was not demonstrated in persons living with HIV who were abusing alcohol
and not prescribed HAART, suggesting alcohol may exert its effects by interacting with
HAART medication (Samet et al., 2003). Drug use (excluding drugs that are smoked) does
not appear to impact HIV disease outcomes per se; however, certain drugs may interact with
HAART and pose problems with medication efficacy (Des Jarlais, 1999). Physical activity
has been related to lower viral load (Bopp et al., 2004), and in a longitudinal sample of 156
HIV-infected men, those who exercised 3-4 times per week were less likely to have
progressed to AIDS or to have died from AIDS at both one and two years post-assessment
(Mustafa, Macer, Thompson, Jackson, & Selassie, 1999). Risky sexual behavior puts
persons with HIV disease at risk for re-infection with a potentially more virulent strain of
HIV or other sexually transmitted disease, and such (re-)infection may accelerate the course
of the disease (Taylor et al., 1992). Although the impact of these behavioral factors on HIV
disease specific outcomes may be minimal, each of these behaviors is listed by the US
Department of Health and Human Services as targets to improving health and reducing risk
of chronic illness, in accord with Healthy People 2010 program (USDHHS, 2000).
Considering that patients with HIV disease are now living longer and increasingly dying of
non HIV-related causes, it is beneficial to persons with HIV disease to engage in healthy
behaviors to promote general health.
Negative psychosocial functioning and health status in HIV disease. Negative
psychological functioning may have a deleterious effect on health outcomes in patients with
HIV disease. For example, in a 7-year study of 1,716 HIV-infected women, those who
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reported symptoms indicating “probable” depression at 75% or great of their study visits
were more than twice as likely to die of AIDS-related causes than were women with limited
or no symptoms (Cook et al., 2004). A 9-year study of 96 HIV-infected men (Leserman et
al., 2002) found that progression to AIDS was associated with highly stressful life events,
high anger, and depressive symptoms. In that study, an increase of one standard deviation in
cumulative anger was associated with a 40% increased risk of developing AIDS (defined as a
CD4+ count < 200 µg/dl). A similar increase in depression translated to a 75% increased
risk of clinical progression to AIDS (i.e., presence of AIDS-defining illness). In a study of
243 injecting drug users, depression predicted progression to AIDS even after controlling for
medication non-adherence (Bouhnik et al., 2005). Accumulating evidence suggests that
depression, anger, and stress can impact health outcomes in HIV disease.
Negative psychosocial functioning and cortisol in HIV disease. Elevated levels of
cortisol have been documented in people at all stages of HIV infection (Christeff et al.,
1997). Additionally, cortisol levels in persons with HIV disease have been reported to covary with negative emotional state. For example, elevated cortisol has been found in HIVinfected individuals who were anxious, depressed (Gorman et al., 1991), and bereaved
(Goodkin et al., 1996). Cortisol reductions in a group of 30 HIV-infected men in a 10-week
relaxation training program were associated with improvements in global mood and
reductions in anxiety (Cruess, Antoni, Kumar & Schneiderman, 2000). For 74 HIV-infected
men, a 10-week bereavement group resulted in decreased cortisol levels and increased CD4+
count (Goodkin et al., 1998). Thus, cortisol appears related to negative emotional states in
persons with HIV disease, suggesting that negative emotions may exert their effects on health
partially by stimulating excess release of cortisol.
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Negative psychosocial functioning and health behaviors in HIV disease. In a
multi-site study of 980 HIV-infected individuals, depressive symptoms were found to be the
strongest correlate of medication non-adherence (Reynolds et al., 2004). Successful treatment
of depression has also resulted in improved medication adherence (Rabkin et al., 1997).
There is evidence from other populations that negative emotions influence rates of smoking,
alcohol intake, and physical activity. One study showed that depression was associated with
greater sexual risk taking behavior and increased recreational drug use in persons with HIV
disease (Kelly et al., 1993). Emotional distress was also shown to be associated with
decreased readiness to quit smoking in a sample of HIV positive individuals (Burkhalter,
Springer, Chabra, Ostroff, & Rapkin, 2005). Hence, negative psychological functioning may
impact health outcomes in persons with HIV disease through decreased medication
adherence and promotion of poorer general health practices.
Positive psychosocial functioning and health status in HIV disease. Positive
emotions were associated with decreased rates of mortality in a sample of 407 HIV-infected
men (Moskowitz, 2003). Participants who reported higher average rates of positive emotions
on the positive affect subscale of the Center for Epidemiological Studies-Depression (CESD) scale were at a reduced risk for AIDS mortality such that for every 1 point increase in
positive affect, risk of death decreased by 14% (Moskowitz, 2003). This study suggests the
possibility of a relation between positive emotions and health outcomes in HIV disease,
though this hypothesis deserves more careful study. For example, because the CES-D
positive affect subscale consists of only 4 items (“I felt that I was just as good as other
people,” “I felt hopeful about the future,” “I was happy,” and “I enjoyed life”), use of a more
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comprehensive measure of affect, such as the well-validated PANAS, (Watson et al., 1988)
may be warranted, and the present study used this more comprehensive measure.
Positive psychosocial functioning and cortisol in HIV disease. Positive emotions
have demonstrated an inverse relation with cortisol levels in the general population (Steptoe
et al., 2005) and this relation has been shown to remain stable across a three year follow-up
period (Steptoe & Wardle, 2005). Unfortunately, there is a dearth of evidence regarding the
influence of positive emotions on cortisol in persons with HIV disease, as no published
studies have directly assessed this relation. This gap in the literature was addressed by the
current study.
Positive psychosocial functioning and health behaviors in HIV disease. In a study
of 2,684 HIV-infected individuals, use of positive coping (e.g., using the situation to grow as
a person) predicted increases in physical activity following HIV diagnosis. Both positive
coping and emotional well-being (e.g., feeling “calm and peaceful”) predicted positive
change in alcohol/drug use following HIV diagnosis (Collins et al., 2001). HIV positive men
with an optimistic attitude towards their ability to control progression of their disease
demonstrated better health practices (a composite of healthy diet, jogging, adequate sleep,
and relaxation) than those with a pessimistic attitude (Taylor, Kemeny, Reed, Bower, &
Gruenewald, 2000). Thus, positive psychological traits may be associated with positive
health practices; however, no published studies located have explored the relation between
trait positive affect and health behaviors in HIV positive individuals. The present study
addressed this knowledge gap.
Contribution to Current Literature
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The current study sought to bring a solid theoretical framework to the evaluation of
the potential mechanisms that may link trait positive emotions to health outcomes.
Voluminous research shows the deleterious effects of negative emotions and negative
psychological functioning in healthy and chronically ill samples, and evidence suggests that
these effects occur via biological and behavioral mechanisms. A number of studies have
demonstrated beneficial effects of positive psychological functioning in both healthy and
chronically ill samples. Other studies have failed to show a relation between positive affect
and health outcomes, and positive affect was associated with increased mortality in specific
cancer populations.
Whether positive emotions relate to health outcomes in any population remains
equivocal, and the potential mechanisms of such effects remain relatively unexplored. The
study of positive emotion is progressing, and the field would benefit from additional studies
focused on positive emotions. The current study explored theoretically based explanations of
the potential benefits of positive emotions. If positive emotions are beneficial to health, it
may be that these benefits are occurring via the same biological and behavioral mechanisms
as negative emotions, a proposition supported by the broaden-and-build model of positive
emotions. An additional question to be explored in this study is whether trait positive
emotions exert their effects independently of the effects of negative emotion or by buffering
against the deleterious effects of negative emotions. These hypotheses are not mutually
exclusive; positive emotions may act both directly and indirectly on health outcomes. The
current study sought to answer some of these questions.
Consistent with the upward spiral theory of positive emotion, three potential
mechanisms, namely cortisol, medication adherence, and health behaviors were hypothesized
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to mediate relations between trait positive affect and health status. In accord with the
undoing theory of positive emotions, trait positive affect was hypothesized to moderate the
relation between trait negative affect and these hypothesized mediators. The specific
hypotheses for this study were as follows:
Hypothesis 1: Total cortisol concentration will mediate the relation between trait
positive emotions and health status as indicated by CD4+ percent, viral load, HIV symptoms,
and self-reported general physical health status. Specifically, high trait positive emotions
will be associated with lower total cortisol concentration. Low total cortisol concentrations
will in turn be associated with higher CD4+ percent, lower viral load, fewer HIV symptoms,
and higher self-reported general health.
Hypothesis 2: Health behaviors will mediate the relation between trait positive
emotions and health status as indicated by CD4+ percent, viral load, HIV symptoms, and
self-reported general physical health status. Specifically, high trait positive emotions will be
associated with higher percent medication adherence and lower negative health behavior
scores. Higher percent medication adherence will be associated with higher CD4+ percent,
lower viral load, lower HIV symptoms, and better self-reported general physical health.
Negative health behaviors will be associated with lower CD4+ percent, higher viral load,
greater HIV symptoms, and higher self-reported general health.
Hypothesis 3: Total cortisol concentration will mediate the relation between trait
negative affect and health status indicators. All relations will be in the opposite direction
from those stated in hypothesis one.
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Hypothesis 4: Health behaviors (negative health behavior composite score and
percent medication adherence) will mediate the relation between trait negative emotions and
health status. All relations will be in the opposite direction from those in hypothesis two.
Hypothesis 5: Trait positive emotions will moderate the relation between trait
negative emotions, total cortisol concentration, percent medication adherence, and negative
health behaviors. Specifically, when higher levels of trait positive affect are present, the
association between trait negative affect and each of these three proposed mechanisms will
become either non-significant or will be significantly reduced in magnitude.
Method
Objective
The primary purpose of this study was to explore the relation between trait positive
and negative emotions and a) health behaviors (including smoking, physical activity,
alcohol/drug use, diet, sexual risk, and medication adherence), b) salivary cortisol, and c)
health indicators (HIV disease related symptoms, CD4+ percent, viral load, and general
physical health), with special emphasis on the relation of positive emotions to these
variables.
Design
This study used a between-subjects cross-sectional design. Participants completed a
one-time psychosocial interview and provided five saliva samples over the course of one day.
Medical care providers in the Virginia Commonwealth University Health Systems Infectious
Disease Clinic (VCUHS ID) provided ratings of current HIV disease-specific
symptomatology, and virulogic and immunologic data were obtained by medical chart
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review. Each participant received a $5 gift card to either Walmart or Target stores (based on
participant preference) and two bus tickets as compensation for their time and effort.
Sample Size Determination
Power analyses were conducted for each model to determine the necessary sample
size. Expected effect sizes were estimated from previous studies on the effects of negative
emotion and positive emotion. The expected effect size for affect and health behaviors was
based on a meta analysis for depression and health behaviors (DiMatteo et al., 2000) and was
estimated to be d =.49. The expected effect size for affect and cortisol was r = .62 based on a
large population based study of positive affect and cortisol (Steptoe et al., 2005). The
expected effect size for affect and health status was d = .39 based on differences in CD4+
cell counts in bereaved and non-bereaved persons living with HIV disease (Goodkin et al.,
1996). Based on the lowest power estimate (.39), alpha of .01, and power of .80, it was
determined that a sample of 67 would be necessary for the proposed study to possess
adequate power to evaluate the primary objectives.
Participants
Seventy HIV-infected individuals were recruited from the VCUHS ID clinic. Fiftythree individuals completed the research interview. Enrollment in the study was
discontinued before the target sample size of 67 persons due to a temporary geographic move
of the present researcher (to complete a clinical internship). Additional enrollment was
considered upon completion of the researcher’s return to the study site; however, the validity
of comparing data collected one year after the original data was questioned considering the
rapidly advancing treatment of HIV disease. Further, preliminary analyses revealed several
statistically significant associations among key study variables with a sample of 53 persons,
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thus it was determined that the sample of 53 was adequate for evaluating the current
hypotheses.
The sample was primarily male (75%) and African American (68%) with the
remaining persons describing their primary ethnicity as Caucasian. Four individuals (8%)
also reported their ethnicity as “mixed” such that two were both Caucasian and Hispanic, one
was both Caucasian and Native American, and one was both African American and Native
American. For purposes of statistical analyses, these four individuals were included with
either the Caucasian or African American groups. The average participant age was 44 years
(SD = 7.8, range = 22-56 years). The current sample therefore reflected a population of
primarily urban-dwelling African American individuals, which is possibly a distinct
population from many studies in HIV which have more frequently sampled from homosexual
populations. This sample may also better represent the national profile of persons living with
HIV disease (CDC, 2007). Requirements of participation included being prescribed
antiretroviral medications (HAART) at the time of enrollment and being between the ages of
18 and 60. Exclusion criteria included recent (within 30 days) symptoms of uncontrolled
psychotic disorder (see Appendix A for psychosis screening questions).
Research Setting
Participants were recruited through the VCUHS ID clinic. This clinic is located in a
major urban teaching hospital in Richmond, Virginia. A total of 1,891 HIV-infected patients
were seen in the clinic during 2005, the year prior to the beginning of the present data
collection. Patient care in this clinic includes multidisciplinary treatment provided by a team
of physicians, nurse practitioners, physician’s assistants, nurses, and social workers.
Screening and Informed Consent Procedures
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Participants were recruited from the waiting room of the clinic by the researcher,
who provided introductory information about the study. Interested participants were
screened in a private room in the clinic and were provided a verbal overview of the study, a
review of the risks and benefits of participating in the study, and were informed of the rights
of study participants. Persons who provided written informed consent (Appendix B) and met
inclusion criteria were enrolled in the study. Once enrolled, each participant was scheduled
for a psychosocial interview. To reduce participant burden, psychosocial interviews were
scheduled for the day of the next medical appointment in the clinic whenever possible. They
were provided with salivettes and verbal and written instructions on the saliva collection
procedure (Appendix C) to be completed on the day before their next appointment. Saliva
collection instructions were to collect saliva five times throughout a single day (upon
awakening, 30 minutes after waking, 12 noon, 5 pm, and 9 pm) and to record cortisolrelevant activities that day using a log (see Measures section below). Times for each saliva
collection were pre-labeled on the 5 collection tubes.
Data Collection Procedure
Participants received a phone call approximately 48 hours prior to their next
appointment. This was done to remind them of their appointment and to review the cortisol
collection procedure. On the day of the next appointment (generally three months after
initial enrollment), participants submitted their saliva samples and cortisol logs, and
completed a 45-minute interview to collect psychosocial data. Data collection appointments
were conducted in a private office in the ID clinic. Saliva samples were delivered
immediately to the General Clinical Research Center (GCRC) for freezing until cortisol
assays were performed on the entire set of all participants’ samples. As part of standard care,
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the ID clinic collects venous samples at each medical visit to monitor virulogic and
immunologic status. Virologic and immunologic data based on the blood samples collected
on the day of data collection were collected by chart review approximately 2 weeks after the
data collection appointment. In several cases, participants did not have their blood sampled
on the day of psychosocial data collection. In those cases, virologic and immune data
collected within three weeks of the participant’s data collection appointment were used.
Studies have shown that while CD4+ total count can vary significantly over the course of
days or weeks, CD4+ percent remains relatively stable over time and is essentially
unchanged when measured over the course of 30 days (Ekouevi et al., 2007). Similarly, viral
load measured by viral RNA has been demonstrated to remain “almost identical” (p. 1985,
Combs et al., 1993) in repeated measurements up to 60 days even in studies published during
the pre-HAART era. Thus, these deviations from scheduled venous sampling can be
considered valid indicators of participants’ virologic and immunologic status around the time
of psychosocial interview.
Measures
Demographics and cortisol log. Demographic data were collected using the
demographic form (Appendix D). Participants were asked to record activities that may
impact cortisol levels on the day they collected saliva samples. The cortisol log (Appendix
E) queried about potential covariates of diurnal cortisol secretion including exercise, alcohol
and tobacco use, medications taken, current happiness/unhappiness rating, symptoms of
illness, hours of sleep the night before saliva collection, time of awakening, and if the
(female) participant was currently menstruating or taking oral contraceptives (Adam &
Kumari, 2009). The happiness/unhappiness ratings on the cortisol log were measured using
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the Emotions Questionnaire (Fordyce, 1988). The Emotions Questionnaire is a brief
assessment tool that asks participants to rate their happiness/unhappiness on a 10 point Likert
scale from very unhappy to extremely happy and then to rate the percent of the reference
period they have felt happy, unhappy, and neutral. The instructions can be varied to reflect
various time frames from “this year” to “today.” On the cortisol log, the instructions asked
participants to rate happiness/unhappiness “today.” The two day test-retest reliability of this
scale is .98, and the four month test-retest reliability is .67; demonstrating that this is a
reliable measure that is also sensitive to change. Validity of this scale is demonstrated by
significant positive correlations with other measures of happiness such as the Affectometer-2
(r = .71) and significant negative correlations with measures of depression such as the Beck
Depression Inventor (r = -.54) (Fordyce, 1988).
Emotion. Trait positive and negative emotions were measured using an extended
version of the PANAS (Tugade & Fredrickson, 2004; Watson et al., 1988; Appendix F). The
original scale asks participants to rate how strongly (from 1=very slightly or not at all to
5=extremely) they have felt each of a list of 20 emotions. Instructions can be varied
depending on the desired time frame. For example, participants can be asked to rate how they
feel “right now”, “during the past year”, or “in general, that is, on the average.” However,
long time frames can introduce retrospective memory biases (Robinson & Clore, 2002) and
assessment of trait or chronic emotional state can be assessed reliably with such time frames
as the past week or past few weeks. Thus in the current study, participants rated their
emotions “during the last few weeks.” Using these instructions, both the positive and
negative affect subscales have a demonstrated internal consistency () of .87 (Watson et al.,
1988). Watson et al. (1988) also report a test-retest reliability (over eight weeks) for the
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positive affect subscale of  = .58 and for the negative affect subscale of  = .48. The
PANAS also demonstrates good convergent validity, with correlations ranging from .76 to
.92 with other brief affect measures (Watson et al., 1988). Eighteen additional items (amused,
angry, anxious, blue, calm, content, curious, depressed, disappointed, discouraged,
disgusted, happy, relaxed, relieved, sad, satisfied, surprised, and tired) that were added to the
PANAS by Tugade and Fredrickson (2004) for studies on the broaden-and-build theory of
positive emotions were also included here. Principle components factor analysis of this
extended version of the PANAS revealed a two factor solution that accounted for 47% of
total variance (compared to 30% in the original PANAS) and a coefficient alpha of .90 for
the positive affect subscale and .84 for the negative affect scale (Tugade & Fredrickson,
2004). Internal consistency in the current sample was  = .92 for the positive affect subscale
and  = .91 for the negative affect scale.
Behavior. Medication adherence was measured using the Terry Beirn Community
Programs for Clinical Research on AIDS medication adherence scale (TBCPCRA, Form 646,
Mannheimer, 2002, Appendix G). This scale assesses percent adherence over the last 7 days
along with reasons for missed doses. Participants were asked to list each medication they
were prescribed and how many of each pill they were to take each day. When participants
were uncertain of the names of their medications, they were shown a chart with photographs
of each pill. If the participant remained uncertain of the name of their medication, the
medication name was coded as “unknown.” They then rated whether they took all, most, one
half, very few, or none of their pills in the last seven days for each medication separately.
These levels of adherence were coded as 100%, 80%, 50%, 20%, and 0% adherence
respectively. Total percent adherence was then calculated by averaging percent adherence
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across all medications. Validity of this scale has been demonstrated by association with
virulogic and immunological outcomes (Mannheimer, 2002). In a large validation study,
100% self-reported adherence using the TBCPCRA was associated with a 12 month 2.77
log10 copies/mL reduction in viral load compared to a 2.33 log10 copies/mL reduction for
those reporting 80-99% adherence and a 0.67 log10 copies/mL reduction in those reporting <
79% adherence. CD4+ cell increases of 179, 159, and 53 cells/µL were also associated with
these respective levels of reported adherence. Percent adherence was analyzed as a
continuous variable in the current study.
Participants were interviewed about their habits regarding diet and physical activity
using the Health Promoting Lifestyles Profile II (HPLP II; Appendix H), which is a revision
of the HPLP (Walker, Sechrist, and Pender, 1988). The HPLP II is a 52-item scale that asks
participants to rate whether they never, sometimes, often, or routinely engage in healthy
behaviors. The HPLP II generates an overall score as well as subscales for physical activity,
nutrition, health responsibility, spiritual growth, stress management, and interpersonal
relationships. This six-factor solution was confirmed by factor analysis in both the HPLP
and HPLP II (Walker et al., 1988; Walker & Hill-Polerecky, 1996). Convergent validity was
demonstrated by r = .68 with the Personal Lifestyle Questionnaire. The scale does not
appear to be subject to social desirability biases (Walker & Hill-Polerecky, 1996). The
HPLP II total score has demonstrated alpha reliability of .93 and subscale alpha reliabilities
range from .75 to .83 (Salyer, Sneed, and Corley, 2001). Alpha reliabilities for the nutrition
and physical activity subscales in the current sample were .50 and .76, respectively.
Alcohol use during the past thirty days was assessed using the quantity frequency
variability method. This method estimates alcohol intake during a selected reference period
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by asking the participant to describe the frequency and quantity of their average alcohol
consumption and the frequency and quantity of heavy atypical alcohol consumption.
Although no “gold standard” exists in measuring alcohol use, a number of self-report
methods are widely used, including diary, quantity frequency (which assess only typical
alcohol intake), quantity frequency variability, and weekly recall (Lemmens, Tan, & Knibbe,
1990). The preferred method of estimating validity of alcohol use measures is by calculating
the extent to which alcohol intake measured by the tool accounts for alcohol sales, a concept
termed coverage. Coverage data supports diary methods over all other methods (coverage of
67% compared to 46-58% for other methods); however, the current study design did not
allow for diary data collection. A quality frequency variability approach was selected due to
a relatively high reported coverage level of 57% (Lemmens et al., 1990) and because a report
from the National Institute on Alcohol Abuse and Alcoholism suggests that accounting for
variability in drinking behavior holds the greatest promise for improving coverage (Dawson,
2003). Slight variations in precise wording occur across different quantity frequency
variability measures. The current study utilized the questions described by Midanik et al. in
their 1998 study (Appendix I), which demonstrated a superior estimation of alcohol intake
using quantity frequency variability when compared to a newer method, the timeline followback technique. Participants were advised to answer each question using the definition of
drink as one 12 ounce can or bottle of beer (or wine cooler), 1 glass of wine, or 1 shot of
liquor. Questions included: 1) During the past 30 days, on how many days did you have at
least one drink of alcohol? 2) During the past 30 days, how many alcoholic drinks did you
usually have in one day on the days that you drank? 3) During the last 30 days, what is the
most number of alcoholic drinks you had in one day? 4) Referring to your answer to
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question 3, on how many days did you have that most number of drinks during the last 30
days? Midanik et al. (1998) also included closed-ended response categories for responses.
This is common in quantity frequency variability formats; however, the current study utilized
an open-ended response format in order to obtain continuous data and to facilitate ease of
administration (Dawson, 2003). Tobacco use was calculated using a similar algorithm
(Appendix J) by multiplying the number of days each participant reported smoking each
week by how many cigarettes they reported smoking on average per day. If the participant
presented a range for number of cigarettes, the midpoint was used for analyses.
Drug use and sexual risk behavior were assessed using the Risk Behavior Survey
(RBS; Appendix K) (University of Washington, 2007). The RBS is a shortened version of
the Risk Behavior Assessment (RBA) developed originally as part of a cooperative
agreement between the National Institute of Drug Abuse and several grantee organizations in
the AIDS Cooperative Agreement program (Community Research Branch, National Institute
on Drug Abuse, 1993). The original RBA takes 30-45 minutes to administer and assesses
lifetime and recent history of drug and sex risk behavior as well as drug treatment history.
The RBA is a modular assessment tool that allows the interviewer to tailor the interview by
skipping to questions that are appropriate given the respondent’s previous answers. Internal
consistency (κ) of the RBA drug use items based on consistent reporting of drug use in the
last 30 days and in the last 48 hours ranged from .82 to 1.0. Test-retest reliability coefficients
for reporting of drug use ranged from .69 to .78. Test-retest reliability for sexual risk
behaviors ranged from .80 to .83 with the exception of a question regarding number of sexual
partners who were injecting drug users (r = .66) (Needle et al., 1995).
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The RBS includes only sections that are focused on drug use and sexual risk behavior
in the last 30 days and requires 6-10 minutes to administer. The RBS drug assessment
section includes cocaine, heroin, cocaine and heroin combined, amphetamines, and opiates.
For drug use, the interviewer asks participants if they have ever used a particular drug, how
often they have used it in the last 30 days, and how often they have injected the drug in the
last 30 days. For sex risk, the RBS assesses number of both male and female sexual partners
in the past 30 days, frequency of different types of sexual behavior (oral, anal insertive, anal
receptive, vaginal insertive, vaginal receptive intercourse) as well as the frequency of using
condoms or dental dams for each sex act. Drug use items were open ended and categorical
response options were provided for frequency of sexual behaviors (seven options from “once
or irregularly” to “four or more times per day”) and what proportion of the time condoms or
dental dams were used for each sex act (five options from never to always) (University of
Washington, 2007). Participants in the current study reported little to no use of heroin,
amphetamines, or opiates in the past 30 days. Seven participants reported using cocaine in
the last 30 days, thus a “used cocaine in the last 30 days” yes/no dichotomous variable was
created to analyze drug use behavior. Similarly, two dichotomous (yes/no) variables,
namely, multiple partners (of any gender), and any incidence of unprotected intercourse (anal
or vaginal), were created that collapsed sex risk behavior across the different categories (cf.,
Bonhert & Latkin, 2009).
To reduce family-wise error in the statistical analyses of multiple health behaviors, a
composite negative health behavior score was created (Tabachnick & Fidell, 2007). Of the
eight individual health behaviors (physical activity, nutrition, medication adherence,
smoking, alcohol use, cocaine use, multiple partners, and unprotected intercourse) that were
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measured in this study, four behaviors were selected based on their moderate to high
intercorrelations (r = .18 and above): alcohol use, tobacco use, physical activity level, and
nutrition. The scores for each of these four behavioral measures were first converted to zscores. Next, physical activity and nutrition were reverse-scored and the negative health
behavior composite was calculated as the mean of the four z-scores. Alpha reliability for this
composite scale was .72. Percent adherence was not included in the composite measure due
to its low correlation with other health behaviors; however, it was retained for a separate
analysis due to a significant correlation with negative affect. Having multiple partners,
engaging in unprotected intercourse, and using cocaine in the last 30 days were dropped from
the primary analyses to be reported here due to low correlations with affect and health status
indicators in preliminary analyses.
Cortisol. Salivary cortisol was collected using Salivettes (Sarstedt AG & Co.,
Numbrecht, Germany), which are small pieces of tubular-shaped cotton that are packaged in
a sterile plastic tube. Cortisol follows a diurnal slope, with levels peaking in the morning and
decreasing throughout the day. For this reason, it is necessary to measure cortisol throughout
the waking hours to assess the diurnal pattern. Cortisol studies often collect saliva multiple
times between waking and bedtime hours, and many researchers have included a collection
point 30 minutes after waking to capture the circadian peak (Adam & Kumari, 2009). Thus,
participants were instructed to collect saliva at five time points over the day by placing the
cotton in their mouth sucking or chewing on the cotton for 2 minutes to ensure complete
saturation before returning the cotton to the capped plastic tube (Hanson et al., 2000).
Participants were instructed to collect saliva immediately upon awakening (prior to smoking,
drinking, brushing teeth, or eating), again 30 minutes later, and then again at 12 pm, 5 pm,
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and 9 pm. Each salivette tube was pre-labeled with the time that the sample should be
collected. Participants received verbal and written instructions at their consent meeting and
brought their samples to their research appointment as described in the data collection
procedure section above. Once the samples were submitted to the researcher, the interview
was completed, and participant incentives had been distributed, each participant was asked to
fill out a saliva collection compliance rating sheet and fold it closed while the researcher left
the room. Each participant was asked to respond to two statements using a 4-point Likert
scale ranging from “All of the time” to “none of the time.” The statements were: 1) for each
saliva collection, I collected my saliva at the time I was asked to collect it, 2) for each saliva
collection, I kept the cotton in my mouth and sucked or chewed on it for two full minutes
each time.
All samples were delivered to the GCRC and frozen upon receipt from each
participant. Cortisol levels of cryopreserved saliva specimens were batch-assayed using
commercial ELISA kits standardized for salivary samples (Salimetrics, Inc.). Highly
qualified personnel of the Core Laboratory of the GCRC performed these assays according to
the manufacturer’s specifications. For total cortisol secretion, an area under the curve with
respect to ground (AUCg) formula was utilized (Pruessner, Kirschbaum, Meinlschmid, &
Hellhammer, 2003).
Health status. Immunologic measures collected by chart review included CD4+ total
cell count, CD4+ percent, and CD4+/CD8+ ratio. CD4+ total cell count and CD4+/CD8+
ratio were collected for general sample reporting; however, CD4+ percent was utilized as the
sole indicator of immunologic status due to its superior stability of measurement. Virologic
status (viral load) was also determined by chart review.
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HIV disease-related symptoms were rated by each participant’s care provider
following their appointment using the Revised HIV Center Medical Staging System
(rHCMSS; Appendix L) (McCain, Lyon, Higginson, Settle, Robins, & Fisher, 1998). The
rHCMSS provides an alternative staging system to that of CDC guidelines. While CDC
guidelines are clinically useful, they provide only nominal data and do not allow for
improvements in disease status because a person’s staging by CDC criteria can only progress
downward. The rHCMSS is based on CDC criteria for defining AIDS and has the advantage
of assessing both presence and severity of AIDS-defining illnesses, as well as providing
ordinal scale data that represent a clinically meaningful measure of disease severity (McCain
et al., 1998). The rHCMSS is significantly correlated with CDC staging criteria (r = .80) and
CD4+ percent (r = -.62), demonstrating good construct validity. Interrater reliability of the
rHCMSS has been reported κ = .95 (McCain et al., 1998).
General symptoms were measured using the physical health composite score from the
RAND 36-Item Health Survey (RAND-36; Appendix M) (Hays, Sherbourne, and Mazel,
1993). The RAND-36 is a publicly available version of the Medical Outcomes Survey 36Item Short-Form health survey (SF-36, Ware & Sherbourne, 1992) The RAND 36-Item
Health Survey contains the same items as the SF-36, but the RAND-36 uses a slightly
different scoring algorithm from the SF-36. The alternative scoring algorithm provides
identical results for six of the eight scales and some differences emerge for the pain and
general health subscales. The RAND-36 scoring algorithm can result in slightly higher scores
on the pain subscale, indicating less pain (mean difference of 3.33 out of possible range of 1
to 100); however, pain scores on the RAND-36 correlate at 0.99 with pain scores on the SF36 (Hayes, Sherbourne, & Mazel, 1993). RAND-36 produces slightly lower scores on the
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general health scale, indicating poorer general health (mean difference of -1.37 out of
possible range of 0 to 100); however, these subscales on the two measures also correlate at
0.99 (Hays et al., 1993). In a summary of 15 studies, internal consistency and test-retest
reliability of the eight subscales of the SF-36 generally exceeded .70 and most exceeded .80.
Concurrent, content, and predictive validity have also been demonstrated in a wide range of
studies (Ware & Gandek, 1998). The RAND-36 measures eight health domains: 1) physical
functioning, 2) role limitations due to physical health problems, 3) bodily pain, 4) social
functioning, 5) general emotional well-being, 6) role limitations due to emotional problems,
7) vitality (energy/fatigue), and 8) general health perceptions. Higher scores on each scale
represent better functioning in that domain. For example, a high pain score indicates
minimal problems related to pain. The eight subscales can also be combined to create a
composite physical health score (physical functioning, role limitations due to physical health,
bodily pain, and general health perceptions) and a composite mental health score (social
functioning, general emotional well-being, role limitations due to emotional problems, and
vitality). The physical health composite score was used to measure self-reported general
health in the current study and demonstrated excellent internal consistency in the current
sample (α = .91).
Chronic burden. To evaluate life events that may impact a participant’s emotional
experience, chronic burden data were also collected. The Chronic Burden scale (Gurung,
Taylor, Kemeny, & Myers, 2004, Appendix N) was developed using focus groups with low
income women at risk for HIV disease. This measure shows appropriate reliability in HIVinfected women and asks participants to report whether or not they experienced each of 22
events during the past month. Participants are then asked to indicate how much of a problem
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each event has been for them on a 4-point Likert scale from 1=not a problem for me in the
last month to 4=A major problem for me in the last month. Although two items possibly
reflect burdens specific to women (“problems arranging childcare” and “being a caregiver for
someone”), these items were maintained as women were included in the present study. Testretest reliability of the Chronic Burden scale was reported as r = .60 (Gurung et al., 2004).
Internal consistency was not previously reported for this scale and was α = .79 in the current
sample.
Statistical Analyses
Data were analyzed using the SAS v 9.1 statistical program. Ordinary Least Squares
regressions were used for all regression analyses. Tests of mediating effects were based on
unstandardized coefficients and standard errors obtained from regression analyses (see
Mediation model). To increase the interpretability of intercepts produced by the regression
models, all continuous independent variables were centered around zero. Categorical data
were reduced to dichotomous variables to reduce spurious variability. Specifically, ethnicity
was recoded as African American vs. Caucasian; marital status was recorded as single vs. not
single, income was coded as below $10,000 vs. above $10,000, education was coded as some
college vs. no college, employment status was coded as on disability vs. not on disability,
vector of infection was coded as sexual contact vs. other, liquor intake on day of cortisol
collection was coded as yes/no, beer intake on day of cortisol collection was coded as yes/no.
Point-biserial and Pearson product moment correlations between potential covariates
(demographic variables, items on the cortisol log) and all dependent variables were examined
to determine entry into the primary regression models reported here. Any potential
covariates that were significantly correlated with DVs at p<.05 were selected for entry into
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primary regression models. Ratings of happiness and percent of day the participant felt
happy on the cortisol log were each highly correlated with trait positive affect (r = .65, .62
respectively), demonstrating consistency between reported trait positive affect and happiness
on the day of cortisol collection. Thus, it was determined that it was unnecessary to control
for happiness on the day of cortisol collection in primary regression analyses.
Model assumption checks. In order to ensure that data met the assumption
requirements for regression analyses, all study variables were examined for missing data,
univariate outliers, and univariate normality. The data were also examined for multivariate
outliers, and residual errors were examined for normality, homoscedascity, and linearity.
Finally, the data were checked for problems with multicollinearity and singularity
(Tabachnick & Fidell, 2007). Some datapoints were observed to be missing (see Treatment
of missing data section below) and univariate outliers and cases of univariate non-normality
were also observed. Outlier data points were identified and winsorised (Tabachnick &
Fidell, 2007) for number of adults living in home (two data points), average number of
cigarettes smoked per day (one data point), total alcohol consumed this month (one data
point), hours of sleep the night before cortisol collection (two data points), minutes of
exercise on the day of cortisol collection (three data points), number of cigarettes smoked on
the day of cortisol collection (one data point), negative affect (three data points) and cortisol
(eight data points across five time collection points). A square root transformation was
performed on minutes of exercise to reduce skewness. A natural log transformation was
applied to total alcohol consumed this month and viral load to reduce skewness and kurtosis
in these measures. Percent adherence was reflected and log transformed to reduce negative
skewness (Tabachnick & Fidell, 2007). For participants whose viral load was undetectable,
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.01 was entered as the value of their viral load in order to accommodate log transformation.
Log transformation is often required to achieve a normal distribution for cortisol; however,
after outliers were winsorised, cortisol scores were within recommended limits (i.e.skewness
and kurtosis values less than 1.5) to be considered normally distributed. Several researchers
have similarly found that raw cortisol data did not require transformation (Carlson, Speca,
Patel, & Goodey, 2003; Moskowitz & Epel, 2006; Steptoe, Wardle, & Marmot, 2005).
Treatment of missing data. Only 41 individuals submitted salivary cortisol
samples. Of these 41 samples, only 34 samples included sufficient saliva on the salivettes for
all five time points and only these 34 complete sets were used for analyses involving cortisol.
Seven (13%) clinician ratings (rHCMSS) were not received. Data for six individuals (11%)
on the chronic burden scale were missing because the scale was inadvertently left out of
those research packets. Some psychosocial data were not obtained because two participants
did not complete all sections of the psychosocial interview and because two interview forms
were inadvertently missing the final page of the RAND-36. In total, two participants were
missing for positive affect and negative affect, three participants were missing the physical
health composite score (RAND-36) and one participant was missing the negative health
behaviors composite score. As the proportion of cases containing missing values exceeded
the recommended 10% for imputing missing data (Allison, 2002), multiple imputation was
used for all missing data except cortisol. Multiple imputation requires that data be missing at
random, thus, dummy codes for missing and non-missing data were created for each variable
which contained missing data. Point-biserial correlations between these dummy variables
and all demographic variables were non-significant (ps > .25), thus it was established that the
data met the missing at random requirement (Allison, 2002). Missing data was imputed
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using PROC MI in the SAS 9.1 statistical package. This technique uses an iterative
maximum likelihood procedure to estimate missing values based on available participant data
and incorporates random variation into the imputation process. Individual imputed datasets
cannot be treated as “real” data due to low standard error estimates, thus multiple imputed
data sets must be created (often between three and 10 data sets) and the variability in
parameter estimates from these imputed data sets can be used for an upward adjustment of
standard errors. The imputed data sets are each analyzed using traditional statistical analytic
procedures (PROC REG in the current analyses) and then a special analysis (here, PROC
MIANALYZE in SAS) is used to combine the parameter estimates from the imputed data
sets to yield estimates that are “consistent, asymptotically efficient, and asymptotically
normal” (Allison 2002, p. 27). The regression models reported here are based on the
combined estimates of five imputed datasets.
Mediation model. The model for testing whether cortisol and health behaviors
mediate relations between affect and health status was based on MacKinnon, Lockwood,
Hoffman, West, and Sheets’ (2002) z’=αβ/σαβ formula for the product of coefficients. The z’
formula is one of a number of approaches that focus on the significance of the total indirect
effect as opposed to traditional causal steps approaches. Causal steps methods (e.g., Baron &
Kenny, 1986) focus on demonstrating that the direct relation of the independent variable (IV)
with the dependent variable (DV) is reduced or eliminated when the mediator is included as a
predictor. There are four steps to the Baron and Kenny (1986) approach: 1) demonstrate a
significant relation between the IV and DV; 2) demonstrate a significant relation between the
IV and the mediator; 3) demonstrate a significant relation between the mediator and the DV;
and 4) demonstrate that when the mediator is statistically controlled, the degree of the
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relation between the IV and DV is reduced. Many methodologists (e.g., Kenny, 2009) now
believe that only a significant indirect effect (i.e. the relation between the IV and the
mediator multiplied by the relation between the mediator and the DV) is required to
demonstrate mediation, and Kenny (2009) advises that coefficients of the individual steps are
better described in terms of “zero” or “non-zero” rather than in terms of statistical
significance as statistical significance is influenced by sample size. Product tests of indirect
effects have gained popularity due to their overall better statistical power and more accurate
Type 1 error rates compared to causal steps approaches. MacKinnon et al. (2002) showed
that the z’ product test demonstrated the highest statistical power and most accurate Type 1
error rate when compared to other tests of indirect effects using statistical simulation
analyses. Given the number of analyses performed, alpha was set to .01 for all z’ tests of
significance to reduce family-wise error rate. All significance tests were one-tailed. Results
significant at p < .05 were considered marginally significant and were deemed relevant for
discussion given that examining mechanisms of positive emotions is a relatively new area of
analysis.
The coefficients and standard errors needed to calculate z’ = αβ/σαβ are obtained by a
two step process. First, α is obtained by regressing each mediating variable on the IV(s) and
any relevant control variables. Second, β is obtained by regressing each DV on each
mediator, the independent variables, and any relevant control variables. Finally, the product
of αβ is divided by a pooled error term that incorporates the standard errors of both α and β.
If the product test using coefficients derived from these regressions is significant, the
proposed intervening variable is said to mediate the relation between the IV and DV.
Because a product term is not a normally distributed variable, z’ has a different sampling
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distribution than the z distribution. The z’ critical values were obtained at
http://www.public.asu.edu/~davidpm/ripl/mediate.htm (MacKinnon et al., 2002).
Results
Sample Characteristics
Demographic characteristics of the sample (age, gender, and ethnicity) were reported
in the Method section. A majority of the 53 participants (n = 32; 64%) were on disability and
36 (72%) reported total household income under $10,000. Eleven participants (21%) had not
finished high school, 18 (34%) had graduated high school, four (8%) completed trade school
beyond high school, 15 (28%) had completed some college level coursework, and five (9%)
had completed a college or graduate degree. Five participants (9%) were married, 10 (19%)
were divorced, four (8%) were widowed, six (11%) were separated, 26 (49%) were
single/never married, and two (4%) were members of an unmarried couple. The average
time since diagnosis was 12.4 years. Twenty-two participants (41%) reported they had been
infected as a result of sexual contact with a male, 11 (21%) reported sexual contact with a
female, four (8%) reported needle sharing, one (2%) reported blood transfusion, and 15
(28%) reported “other” or “unknown” method of infection.
Emotion Reporting. Descriptive statistics for all major study variables are shown in
Table 1. In examining total affect scores (original and extended PANAS items), participants
in the current study reported high levels of both positive affect (PA) and negative affect (NA)
compared to the sample in Tugade and Fredrickson’s (2004) study (mean PA = 51.72 (SD =
11.66), mean NA = 26.68(SD = 6.12)). The Tugade and Fredrickson study was measuring
current rather than trait affect, and affect scores increase as time frame of the measured
reference period increases when using the PANAS (Watson, Clark, & Tellegen, 1988),
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however, these scores likely reflect an elevation above and beyond that associated with the
reference period. Other studies have documented elevated reporting of both positive and
negative emotions in persons with HIV disease using the PANAS (e.g. DeMarco, Johnsen,
Fukuda, & Deffenbaugh, 2001) and these elevated levels of reporting both positive and
negative emotion may reflect the impact of living with a chronic stressor such as HIV
infection. However, when just the original PANAS items were considered, mean trait affect
in the current sample was comparable to means reported by Watson, Clark, and Tellegen
(mean PA = 32.0 (SD = 7.0), mean NA = 19.5 (SD = 7.0)).
Cortisol. Participants in the current sample demonstrated waking and evening
cortisol concentrations that were within the expected range. In healthy adults, cortisol
concentrations upon awakening typically show a mean of .39 µg/dl and range from 0.11 to
1.55 µg/dl, and evening cortisol concentrations typically show a mean of .07 µg/dl and range
from .02 to .36 µg/dl (Aardal & Holm, 1995). As shown in Table 1, the average waking
cortisol was .34 µg/dl and evening cortisol was .22 µg/dl in the current sample. Although
within the expected range, evening cortisol was somewhat high in the current sample. This
may partly be due to final cortisol measurement at 9 pm in the current sample compared to
10 pm in the reference sample and could also reflect disruptions in normal circadian rhythm.
Behavioral reporting. Participants were prescribed to take an average of 4.5 pills
per day for managing HIV disease with a range from one to 15 pills. This represents a
downward shift from previous studies. Participants in a combination antiretroviral study
reported being prescribed between 10 and 25 pills per day for managing HIV disease with a
median of 16 pills (Chesney et al., 2000). This shift is to be expected with advancements in
treatment and reflects the increasing use of combination therapies such as Atripla, Combivir,
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Epzicom, Trizivir, and Truvada which combine multiple medications into a single pill. As
shown in Table 1, the average percent medication adherence in the present study was 82%.
Thirty-five participants (66%) reported 100% medication adherence during the past seven
days, 10 (19%) reported 80-99% adherence, and eight (15%) reported 0-79% adherence.
These three levels of adherence correspond to the stratifications used in validating the
medication adherence measure and significant decreases in virulogic and immunologic
response to medication were associated with each descending level of adherence
(Mannheimer, 2002). Of the 37 participants who submitted cortisol collection compliance
information, 27 of these (73%) reported that they had “always” collected their saliva samples
at the times indicated on the tubes, nine (24%) reported that they had collected at the
appropriate time “most of the time” and one reported collecting saliva at the correct times
“none of the time.” For correctly keeping the salivette in their mouth for two full minutes, 33
(89%) of the 37 reporting participants indicated that they had done so “all of the time” and
four of these participants (11%) indicated doing so “most of the time.”
Thirty-two (61%) of the full sample of participants reported current smoking
behavior. On average, participants reported smoking 43 cigarettes per week (see Table 1).
The average number of total drinks in the past 30 days was 18 drinks. Thirty-nine (75%)
reported some lifetime cocaine use and seven (14%) reported cocaine use in the last 30 days.
For the remaining drug classes, 27% reported lifetime use of heroin, 17% lifetime use of
heroin/cocaine combined, 12% lifetime use of opiates, and 21% lifetime use of
amphetamines. One participant reported using opiates and amphetamines in the last 30 days
and no participants reported heroin, heroin/cocaine use, or injecting any kind of drug in the
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Table 1.
Descriptive Statistics for All Continuous Major Study Variables (before data corrections).
Mean

SD

N

Total PA

63.02

16.01

51

Total NA

45.57

14.46

51

Original PANAS only PA

34.25

9.49

51

Original PANAS only NA

21.86

7.33

51

Extended PANAS items only PA

28.76

8.07

51

Extended PANAS items only NA

23.71

8.19

51

Waking Cortisol (µg/dl)

0.34

0.23

34

Evening Cortisol (µg/dl)

0.22

0.16

34

.82

.34

53

Cigarettes per week

43.11

52.50

52

Alcoholic beverages in past 30 days

17.76

54.62

52

Physical Activity Score

2.25

0.68

53

Nutrition Score

2.34

0.47

53

487.00

436.66

53

.19

.09

53

0.44

0.28

53

11065.82

47848.93

53

rHCMSS

16.26

12.36

46

General Physical Health Score

59.59

9.18

50

Percent Medication Adherence

CD4+ Total (cells/µL)
CD4+ Percent
CD4+/CD8+ Ratio
Viral Load (copies/ml)
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past 30 days. Five participants (10%) reported having multiple sex partners in the past 30
days with number of reported partners ranging from zero to 20. Eight (16%) participants
reported at least one incidence of unprotected vaginal or anal intercourse during the past 30
days.
Health status. As described in Table 1, mean CD4+ cell count for this sample was
487 cells/µL, with cell counts ranging from 12 to 2670. Healthy CD4+ cell counts range
from approximately 400-1600 cells/µL (Lifson et al. 1991), thus the current sample likely
reflects both CD4+ dysfunction and the high variability in this indicator. Twelve participants
(23%) had CD4+ cell counts below 200 cells/µL, indicating immunologic progression to
AIDS (CDC, 2004). Mean CD4+ percent in healthy adults has been estimated to be
approximately 44% (Boffil et al., 1992) and mean CD4+ percent was 19.5% in the current
sample. Mean CD4+/CD8+ ratio in healthy adults has been estimated to be 1.49 with a
standard deviation of .57 (Jiang et al., 2004). Mean CD4/CD8 ratio was .44 in the current
sample, 1.84 standard deviations below the mean ratio observed in healthy adults. Mean
viral load in the current sample was 11,066 copies/ml, with 29 (55%) of participants
demonstrating undetectable viral load. Undetectable viral load means that the number of
copies of HIV present in the peripheral blood sample was below the minimum threshold of
detection. Undetectable viral load is often interpreted as an indicator of successful HAART
treatment (Ledergerber et al., 1999). The average of clinician-provided HIV symptom
ratings using the rHCMSS was 16 out of a possible 39, which falls in the range of “minor
symptoms.” Symptom scores in the sample ranged from 0 to 39, indicating a full range of
current symptomatology from asymptomatic to severe AIDS-defining illnesses. Descriptive
statistics of the health status indicators and all major study variables can be found in Table 1.
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Preliminary Analyses
Bivariate correlations between all study variables (presented in Table 2) were
examined as a preliminary means of evaluating relations between all variables. The pattern
of correlations indicated a number of significant relations across affect variables, mediator
variables, and dependent variables, thus further evaluations of specific hypotheses were
pursued.
Primary Analyses
Hypothesis 1: Total cortisol concentration mediates the direct relation between
trait positive affect and improved health status. If cortisol serves as a mediator between
positive affect and health indicators in persons living with HIV disease, the product of the
regression coefficients that make up the indirect effect should be statistically significant
using the z’ distribution. Regressions derived from multiple imputation were completed in
order to obtain unstandardized regression coefficients and standard errors for conducting the
product test. First, the mediator, AUCg, was regressed on both positive affect (PA) and
negative affect (NA) and control variables. PA and NA were entered simultaneously to
obtain coefficients that would reflect the relations for each type of affect after controlling for
the effects of the other type of affect. Based on preliminary analyses (see Statistical Analyses
section), chronic burden and smoking on the day of cortisol collection served as control
variables for the prediction of AUCg. When the regression was completed for AUCg, a
suppression effect was noted such that positive affect was suppressing the effect of negative
affect when they were simultaneously entered into the model. A suppression effect is also
known as inconsistent mediation (MacKinnon, Krull, & Lockwood, 2002). Inconsistent
mediation occurs when a third variable (positive affect in this case) increases rather than
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Table 2.
Intercorrelations among Study Variables (N = 53 for all except AUCg, N = 34).

1

2

3

4

5

6

7

8

1. Positive Affect
2. Negative Affect

-.51**

3. AUCg

-.44**

.08

.10

-.31*

4. Percent Adherence
5. Neg. Health Behaviors

-.64**

.01

.46** .25

6. CD4+ Percent

.20

-.14

-.35*

7. Viral Load

-.05

.24

-.04

8. HIV symptoms

-.03

.09

9. General Health

.32*

.46** -.31* -.29

-.17
.20

-.17

-.42**

.06

-.59**

.02

.08

-.22

-.04

.03

-.29

.02

-.11

-.16

*p<.05, **p<.01

decreases the relation between an IV (negative affect) and a DV (AUCg). Suppression is
detected when the regression coefficient for the relation between the IV and DV is either
greater than the bivariate correlation between the two variables or the sign of the coefficient
is in the opposite direction of the correlation. The reason this occurs is typically because the
suppressing variable (positive affect) explains variance in the suppressed variable (negative
affect) (MacKinnon et al., 2002; Tabachnick & Fidell, 2007). The correlation between
negative affect and AUCg (N = 34, r = .08) was non-significant, but was positive, which is
consistent with findings in previous research. When entered into a regression with positive
affect, however; the sign of the unstandardized regression coefficient was negative (b = -
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2.89), indicating suppression had occurred. Due to the suppression effect, separate models
were run regressing AUCg on positive and negative affect separately, as well as the same
control variables described above. The unstandardized regression coefficient for positive
affect dropped from b = -4.41 in the PA-NA model to b = -3.42 in the PA only model,
suggesting that NA was similarly suppressing PA.
To obtain coefficients for the second half of the indirect effect (i.e. the coefficient of
the relation between the mediator and the DVs controlling for the effects of the IV), CD4+
percent, viral load, HIV symptoms (rHCMSS), and general physical health (RAND-36) were
each regressed (that is, in separate models) on the control variables, affect terms, (PA and
NA entered into separate models again due to suppression effect), and AUCg entered as
predictors. Chronic burden, ethnicity, and income were entered as control variables for
CD4+ percent. Chronic burden and number of children residing with the participant were
entered as control variables for viral load. Age, ethnicity, and disability status were entered
as control variables for HIV symptoms. No control variables were entered for general health
status. Among the four outcomes analyzed, a significant mediation result was found for one
outcome, and two outcomes were marginally significant. Table 3 shows multiple regression
results used to calculate product tests for hypothesis 1. Product tests using the coefficients
and standardized errors obtained from the regression analyses demonstrated that AUCg
mediated the relation between PA and CD4+ percent (z’ = 1.11, p < .01). Specifically, higher
trait PA was associated with lower AUCg (β = -.35, p < .05), and lower AUCg was
associated with higher CD4+ percent (β = -.27, n.s.). Figure 1 demonstrates the differences
between persons reporting high vs. low trait positive affect in mean cortisol concentrations
across the five saliva collection times. Figure 2 demonstrates the significant mediation
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Table 3.
Multiple Regression Results Testing AUCg as a Mediator of the Relation Between Trait
Positive Affect and Health Indicators (N = 34).
B

S.E

p________

-3.42

1.63

0.04

Step 1 (α): IV = PA
AUCg

Step 2 (β): IV = AUCg (controlling for PA and Control Variables)
CD4+ percent

-0.02

0.01

0.19

Viral Load

-0.0004

0.003

0.91

rHCMSS

0.02

0.02

0.27

General Health

-0.01

0.01

0.97

described. AUCg was also a marginally significant mediator of the relation between PA and
HIV symptoms (z’ = -.98, p <.02) and general health symptoms (z’ = .78, p < .05). Again,
higher PA was associated with lower total cortisol concentration (β = -.35, p < .05), and
lower cortisol was associated with fewer HIV symptoms (β = .22, n.s.) and
better general health scores (β = -.17, n.s.). AUCg did not mediate the relation between trait
PA and viral load (z’ = .12, p > .30). None of the control variables were significantly
associated with AUCg, CD4+ percent, HIV symptoms, or general health symptoms in
regression analyses (all ps > .06). Higher number of children residing with the participant
was associated with higher viral load (β = .40, p < 05).
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0.50
0.45
0.40

Cortisol

0.35
0.30
0.25
0.20
0.15
0.10
0

1

2

3

4

5

6

Time
Low Positive Affect
High Positive Affect
Figure 1. Different patterns in mean cortisol concentrations across 5 time points for
persons reporting high vs. low trait positive affect

AUCg
-3.42*
Positive
Affect

-.02

.12 (.09)

CD4+
Percent

*p < .05
Figure 2. AUCg mediates relation between high trait positive affect and high CD4+ percent.
Numbers indicate unstandardized regression coefficients. Numbers in parentheses indicate
the new coefficient after including the mediating variable.
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Hypothesis 2: Health behaviors and medication adherence mediate the direct
relation between trait positive affect and improved health status. In accordance with
hypothesis 2, negative health behaviors (a composite score of alcohol and tobacco use,
physical activity levels, and nutrition) and medication adherence were evaluated as potential
mediators between PA and health status. Following the same multiple imputation procedure
described above to obtain coefficients and standard errors, negative health behaviors and
percent adherence were regressed on six control variables and affect terms. A suppression
effect was not noted in the regression analyses conducted to obtain coefficients and standard
errors for health behavior product tests. Therefore, PA and NA were entered simultaneously
in all regressions for this product test in order to obtain coefficients that controlled for the
effects of the other type of emotion. Control variables for negative health behaviors were
education status, income, and vector of infection. Age was entered as a control variable for
medication adherence. A suppression effect was again noted for PA and NA in the
medication adherence model, so separate PA and NA models were utilized for product tests
involving medication adherence. Next, CD4+ percent, viral load, HIV symptoms, and
general health symptoms were regressed on the same control variables described above, the
affect terms, and the health behaviors. Table 4 shows multiple regression results used to
conduct product tests for hypothesis 2. Product tests revealed that neither medication
adherence nor negative health behaviors mediated relations between PA and health status (z’
values ranged from .08 to .37, all ps > .16). None of the control variables were significantly
associated with health behavior composite score or with medication adherence (all ps > .06).
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Table 4.
Multiple Regression Results Testing Medication Adherence and Negative Health Behaviors
as Mediators of the Relation Between Trait Positive Affect and Health Indicators (N = 53).
B

S.E.

p________

Step 1 (α): IV = PA
Medication Adherence

0.002

0.007

0.82

Negative Health Behaviors Index

-0.22

0.01

<.0001

Step 2 (β): IV = Medication Adherence (controlling for PA and Control Variables)
CD4+ percent

3.06

1.55

0.05

Viral Load

-1.30

1.40

.001

rHCMSS

0.50

2.24

0.82

General Health

-0.15

1.62

0.92

Step 2 (β): IV = Negative Health Behavior Index (controlling for PA and Control Variables)
CD4+ percent

-0.39

2.71

0.89

Viral Load

0.25

0.66

0.71

rHCMSS

0.74

3.41

0.82

General Health

0.26

2.33

0.91

Hypothesis 3: Total cortisol concentration mediates the inverse relation between
trait negative affect and improved health status. Unstandardized coefficients and standard
errors were derived from the multiple imputation regressions already described. AUCg was
evaluated as a potential mediator of the relation between NA and health status variables.
Table 5 shows multiple regression results used to calculate product tests for hypothesis 3.
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Product test results indicated that AUCg did not mediate any relations between NA and
health status indicators (z’ ranged from .26 to .43, all ps >.14).
Table 5.
Multiple Regression Results Testing AUCg as a Mediator of the Relation Between Trait
Negative Affect and Health Indicators (N = 34).
B

S.E

p________

0.86

1.93

0.66

Step 1 (α): IV = NA
AUCg

Step 2 (β): IV = AUCg (controlling for NA and Control Variables)
CD4+ percent

-0.02

0.01

0.08

Viral Load

-0.001

0.003

0.75

rHCMSS

0.02

0.01

0.22

General Health

-0.02

0.01

0.12

Hypothesis 4: Health behaviors and medication adherence mediate the inverse
relation between trait negative affect and improved health status. Unstandardized
coefficients and standard errors obtained from multiple imputation-based regression analyses
previously described were used to test both negative health behaviors and medication
adherence as potential mediators of the relation between PA and health status in accordance
with hypothesis 4. Table 6 shows multiple regression results used to calculate product tests
for hypothesis 4. Medication adherence significantly mediated the relation between NA and
CD4+ percent (z’ = -1.33, p < .01) and between NA and viral load (z’ = 1.61, p < .01). The
direction of the individual coefficients were in the
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Table 6.
Multiple Regression Results Testing Medication Adherence and Negative Health Behaviors
as Mediators of the Relation Between Trait Negative Affect and Health Indicators (N = 53).
B

S.E

p________

Medication Adherence

-0.01

0.01

0.05

Negative Health Behaviors Index

0.01

0.01

0.21

Step 1 (α): IV = NA

Step 2 (β): IV = Medication Adherence (controlling for NA and Control Variables)
CD4+ percent

3.01

1.64

0.07

Viral Load

-1.25

0.43

0.004

rHCMSS

0.81

2.35

0.73

General Health

-0.82

1.78

0.02

Step 2 (β): IV = Negative Health Behavior Index (controlling for NA and Control Variables)
CD4+ percent

-0.39

2.71

0.89

Viral Load

0.25

0.66

0.71

rHCMSS

1.09

3.41

0.82

General Health

0.26

2.33

0.91

expected direction such that high negative affect was associated with lower percent
medication adherence (β = -.26, p < .05) and lower percent medication adherence was
associated with lower CD4+ percent (β = .25, n.s.) and higher viral load (β = -.38, p < .01).
Figure 3 shows these mediation relations. Medication adherence did not mediate any
relations between trait NA and HIV symptoms (z’ = -.34, p > .19) or NA and general health
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(z’ = .45, p > .12) Negative health behaviors did not mediate any relation between NA and
health status indicators (z’ ranged from .11 to .36, all ps > .17).
Hypothesis 5: Trait positive affect moderates the direct relation between high
trait negative affect and increased total cortisol concentration, poorer medication
adherence, and higher negative health behavior scores. Upon examination of bivariate
correlations for the data from the current sample, PA and NA were found to be
Percent
Adherence

Percent
Adherence
3.01

-.01*
Negative
Affect

-1.25**

-.01*
CD4+
percent

Negative
Affect

-.08(-.03)

Viral Load
.02(.003)

* p<.05 **p<.01
Figure 3. Percent medication adherence mediates the relations between high trait negative
affect and lower CD4+ percent and higher viral load. All numbers indicate unstandardized
regression coefficients. Numbers in parentheses indicate the new coefficient after including
the mediating variable.

moderately correlated at r = -.51 (N = 53). According to Baron & Kenny (1986), evaluating
moderation between variables with a moderate correlation is not recommended due to
problems in interpretation. Specifically, “it is desirable that the moderator variable be
uncorrelated with both the predictor and the criterion [the dependent variable] to create a
clearly interpretable interaction term” (Baron & Kenny, 1986, p. 1174). When two variables
are moderately inversely correlated (as in the current case), their interaction term is difficult
to interpret because participants who are low on one measure tend to be high on the other
measure. This moderate correlation was unexpected as the PANAS was selected for its
relative independence of PA and NA. One possible reason for the higher correlation in this
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sample was the inclusion of additional low-activation affect terms from Tugade and
Fredrickson’s (2004) extended version of the PANAS. The correlation between PA and NA
including only the extended (low activation) items was r = -.55 (N = 53). However, in
examining the correlation for only the original PANAS items (high activation), they were
also moderately correlated at r = -.43 (N = 53). Even at this level, interpreting interactions
would have to be viewed with extreme caution; thus, data in the current sample did not allow
for exploration of a moderation hypothesis.
Secondary Analyses
Although the composite negative health behavior variable was not found to mediate
relations between affect and health status (Hypotheses 2 and 4), it was of interest to examine
the relations of both PA and NA with the individual behaviors that were combined to create
the health behavior composite (alcohol consumed in the past 30 days, cigarettes smoked per
week, nutrition, and physical activity levels). Because these specific behaviors are likely to
impact long-term health outcomes (USDHHS, 2000), it is possible that mediation was not
confirmed in the current sample due to cross-sectional design. Future prospective analyses;
however, could be justified by demonstration of a cross-sectional relation between trait affect
and specific health behaviors. Each of these four health behaviors were regressed with
control variables and both PA and NA entered simultaneously. Chronic burden, education,
income, and vector of infection were entered as control variables for the smoking DV.
Chronic burden and gender were entered as control variables for the alcohol DV. Education
and income were entered as control variables for the physical activity DV. Education and
number of children residing with the participant were entered as control variables for
nutrition. After controlling for the effects of the control variables and NA, high reported
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levels of trait PA were associated with lower alcohol consumption (F (4, 47) = 3.10, R2 = .26,
β = -0.35, p < .05), greater physical activity (F (4, 48) = 3.89, R2 = .24, β = 0.39, p < .01),
and better nutrition (F (4, 48) = 3.68, R2 = .22, β = 0.34, p < .05). PA was not significantly
associated with the smoking DV (β = -.27, p < .07). NA was not significantly associated
with any of these behaviors after controlling for the effects of control variables and PA, (all
ps > .36). Vector of infection was significantly associated with the smoking DV such that
persons infected by means other than sexual contact (i.e. intravenous drug use, blood
transfusion, or “unknown” source of infection) reported smoking more cigarettes per week
than those infected through sexual contact (β = -.34, p < .01). No other control variables
were significantly associated with health behaviors. Tables 7-9 display multiple regression
results for alcohol intake, physical activity scores, and nutrition scores.
Table 7.
Multiple Regression Results for Total Alcohol Intake in Past 30 Days and Trait Positive and
Negative Affect (N = 52).
Variable

β

t

p

Chronic Burden

0.12

0.83

0.41

Gender

0.20

1.55

0.12

-0.35

-2.28

0.02

0.02

0.10

0.92

Control

Independent
Positive Affect
Negative Affect
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Table 8.
Multiple Regression Results for Physical Activity Scores and Trait Positive and Negative
Affect(N = 53).
Variable

β

t

p

0.17

1.36

0.18

-0.16

-1.22

0.22

Positive Affect

0.39

2.52

0.01

Negative Affect

-0.08

-0.55

0.58

Control
Education
Income
Independent

Table 9.
Multiple Regression Results for Nutrition Scores and Trait Positive and Negative Affect (N =
53).
Variable

β

t

p

Education

0.16

1.25

0.21

# of Children

0.18

1.47

0.14

Positive Affect

0.34

2.27

0.02

Negative Affect

-0.14

-0.90

0.37

Control

Independent
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Discussion
The primary purpose of this study was to evaluate whether trait positive and negative
emotions in persons living with HIV disease relate to neuroendocrine responding, health
behaviors, and health status in a manner that is consistent with the biobehavioral model and
the broaden-and-build theory of positive emotions. Specifically, cortisol, medication
adherence, and negative health behaviors were examined as potential mechanisms of the
relation between both positive and negative trait affect and health status in a sample of
persons living with HIV disease. The current results partially support relations between trait
positive and negative affect and HIV-specific health status that is mediated by physiological
responses and health behaviors. These findings are discussed in more detail in what follows,
according to each hypothesis evaluated.
Total Cortisol Concentration Mediates the Relation between Trait Positive Affect and
Health Status
The first hypothesis of this study stated that cortisol would mediate the relation
between trait positive affect and four indicators of health status in persons with HIV disease
(CD4+ percent, viral load, HIV symptoms, and general health). This hypothesis was
developed in consonance with the upward spiral theory (Fredrickson, 2000) which states that
positive affect is associated with the development of physical, psychological, social, and
intellectual resources. This study demonstrated that total cortisol concentration measured
across one day significantly mediated the relation between high trait positive emotions and
better current health status as indicated by higher CD4+ percent. Lower AUCg also
demonstrated marginally significant mediating relations between high trait positive affect and
lower HIV symptoms and higher general health status. Thus, trait positive affect may be

64

associated with development of physical resources through enhanced neuroendocrine
functioning (Fredrickson, 2000), which is in turn associated with improved health status in
persons with HIV disease. This result extends previous findings that lower total cortisol
concentration is generally associated with high levels of positive affect (Steptoe et al., 2005)
and better health in healthy populations (Danner et al., 2001). This is the first known finding
of this effect in a sample of persons with HIV disease.
Health Behaviors Mediate the Relation between Trait Positive Affect and Health Status
Also consistent with Frederickson’s (2000) upward spiral theory, health behaviors
were hypothesized to mediate the relation between trait positive affect and better health
status. Trait positive affect was associated with several adaptive health behaviors,
specifically lower alcohol intake, greater physical activity, and better nutrition habits;
however, no role was found for health behavior mediation of the affect – health status
relations. Given that these behaviors are more likely to impact long term health (USDHHS,
2000) these behaviors may not yet have begun to demonstrate an effect on health due to the
relatively young age of the current sample (average age was 44, range 22-56). Longitudinal
studies or cross-sectional studies that specifically target older participants may bear out this
mediating hypothesis. Ingledew and McDonaugh (1998) found that health behaviors can
serve coping functions. Thus, current findings support the possibility that positive emotions
contribute to the development of positive coping resources. The degree to which these
behaviors impact HIV specific mechanisms is certainly equivocal; however, as persons living
with HIV disease are now able to anticipate greater life expectancy than was the case in the
pre-HAART era, targeting healthy lifestyles is of equal importance to enhancing medication
adherence in managing HIV disease.
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Inconsistent with hypothesis 2, medication adherence did not mediate the relation
between high trait positive affect and better health status. Further, the bivariate correlation
between positive affect and medication adherence was non-significant. Although previous
studies have shown that depression is associated with poor medication adherence in persons
living with HIV (Reynolds et al., 2004), no previous studies located have examined the
relation between positive affect and medication adherence in persons living with HIV
disease. The current study failed to support a relation between positive affect and medication
adherence.
Total Cortisol Concentration Mediates the Relation between Trait Negative Affect and
Health Status
Hypothesis 3 stated that total cortisol concentration would mediate an association
between high negative affect and poorer health status. This hypothesis was not supported in
the current sample. This is inconsistent with previous findings that total cortisol
concentration is associated with poor psychosocial functioning (e.g Leserman et al., 2002)
and poor health status (e.g. Polk, et al., 2005); however, such inconsistencies in cortisol data
are not uncommon (Adam & Kumari, 2009). It is not clear why positive affect was
associated with total cortisol concentration while negative affect was not in the current
sample. As discussed in the Introduction, a consensus has not yet been reached about the
best way to measure trait negative emotions as they relate to total cortisol concentration. It is
possible that the extended version of the PANAS used in the current study may not be the
ideal instrument for capturing the relation between trait negative affect and cortisol, although
it showed promise in demonstrating the association between trait positive affect and cortisol.
This could reflect a measurement problem with the PANAS in regard to capturing the
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relation between trait negative affect and total cortisol concentration or a more general
challenge with assessing trait negative affect. Polk et al. (2005) measured affect across six
days over the course of two weeks and summed those ratings to develop an index of trait
affect. The current study used a one-day retrospective report of emotions experienced over
the past few weeks. Although the current method seems to have been effective in capturing a
relation between trait positive affect and total cortisol, perhaps Polk et al.’s approach is more
suitable for assessing trait negative affect as it may help to avoid retrospective biases that can
be associated with global one-occasion reports.
As noted in the Introduction, few studies have focused on the relation between trait
negative emotions and total cortisol concentration, and while one study has demonstrated a
relation between high trait negative emotions and high total cortisol concentration (Polk et al,
2005) another study failed to demonstrate this effect (Hanson et al., 2000). Additional work
is needed to determine if trait negative affect is truly associated with cortisol and to identify
the best means of capturing this relation. Perhaps a more fine-grained approach that isolates
specific trait emotions such as anger, sadness, or anxiety is necessary to clarify this relation.
Denson, Spanovic, and Miller (2008) propose that classifying emotions into broad positive
and negative categories is too non-specific to detect relations between emotion and cortisol
responding. They have proposed an integrated specificity model, which posits that specific
emotions produce specific physiological outcomes based on different survival demands. In
support of their theory, they performed a meta-analysis in which trained judges determined
the specific emotions and cognitive appraisals likely to be produced by specific experimental
procedures. They compared the effect sizes of the relations between these procedures and
measures of cortisol responding and found that surprise and cognitive appraisals of
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challenge, novelty, and intensity were associated with elevated cortisol response. Other basic
emotions (happy, sad, anticipation, disgust, anger, fear, and acceptance) were not associated
with cortisol response according to their analysis. While these findings are specific to studies
of experimentally manipulated state emotions, the specific emotion approach may also apply
when measuring trait negative emotion.
Another possible explanation is offered by findings in a recent study by Wrosch,
Miller, Lupien, and Pruessner (2008). They suggested that inconsistencies reported in the
associations between psychosocial functioning, cortisol, and health status are related to
failures to include other important health mediators in many studies. Specifically, in a
sample of older adults, they found that high cortisol levels predicted increase in physical
symptoms over the course of two years only if both trait negative affect and disturbances in
sleep efficiency were also present. Interestingly, efficient sleep buffered against the
prospective increase in physical symptoms that was associated with trait negative affect and
cortisol. Sleep efficiency was not assessed in the current study, and perhaps the failure to
demonstrate a mediating role of cortisol in the relation between trait negative affect and
health status in the current sample is related to lack of inclusion of sleep efficiency or other
important health mediators.
One final possible explanation is that although total cortisol concentrations
throughout the day did not differ between participants reporting high and low trait negative
affect, neuroendocrine dysfunction could still be present in the sample in that there could be
alterations in circadian rhythm (e.g. flattened rhythm, nighttime rise, flattened slope, etc.)
that were not considered in the current analysis (Adam & Kumari, 2009).
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Health Behaviors Mediate the Relation between Trait Negative Affect and Health
Status
As predicted, high trait negative affect was associated with poorer medication
adherence, and poor adherence mediated the relation between high trait negative affect and
poorer health status as indicated by lower CD4+ percent and higher viral load. This is
consistent with previous findings linking poor adherence to negative psychological
functioning (Reynolds et al., 2004) and to poor immunologic and viral outcomes (Kitahata et
al., 2004; Mannheimer, 2002). This further highlights the importance of targeting
psychosocial factors in providing comprehensive HIV disease management. Inconsistent
with hypothesis four, rates of smoking, drinking alcohol, physical activity levels, and
nutrition habits did not mediate the relation between trait negative affect and health status.
Health behaviors also did not mediate relations between trait positive affect and health status
(hypothesis 2), although trait positive affect was associated with lower levels of alcohol
intake, greater physical activity, and better nutrition habits. This failure to demonstrate
mediation effects of health behaviors for both positive and negative affect may extend
beyond the issues of cross-sectional design and the young age of the current sample. The
presence of a chronic illness such as HIV disease may create downward pressure on the
relation between affect, health behaviors, and health status in that the disease process may
supercede any effects of health behaviors and affect.
Limitations and Future Research
Although the current study adds to the growing literature on trait positive and
negative emotions and physical health, there are some limitations to the present research that
deserve discussion and that point to improvements for future research. The most important
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limitation of this study is its cross-sectional design, which does not allow for causal
interpretations of the current findings. One cannot rule out the possibility that emotional
experience “over the past several weeks” (as was assessed here) had been influenced by
health status, cortisol levels, or the practice of negative health behaviors. As mentioned in
the Introduction on the relation between cortisol and depression, there likely are bidirectional relations between health status, neuroendocrine responding, behavioral
functioning, and affect. However, the current findings help to provide a rationale for future
prospective studies that can track the temporal relations between the variables assessed here,
and in particular contribute further to the body of literature focused on the portion of the
temporal chain in which psychosocial factors influence health outcomes.
A second limitation of the present research is also methodological, and concerns the
measurement of diurnal cortisol. Salivary cortisol was assessed over the course of a single
day and self-reported compliance data were collected in the current study. Single day
salivary cortisol assessments are not uncommon in the literature (Adam & Kumari, 2009);
however, collecting samples over a two to six day period would likely have provided better
reliability in assessing the relation between trait affect and cortisol (Helhammer et al., 2007).
Although participants reported high rates of compliance in the current study, a recent study
using electronic monitoring of collection times of which the participants were unaware,
demonstrated that participants reported 91% adherence to saliva collection protocol while
their actual adherence was 73% (Broderick, Arnold, Kudielka, & Kirschbaum, 2004).
Although electronic monitoring devices are costly, they enhance adherence, as demonstrated
by findings that actual adherence increased to 90% in the group of participants who were
made aware of the monitoring device in this study (Broderick et al., 2004). Future studies
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that include longer periods of cortisol assessment and rigorous monitoring of salivary cortisol
collection adherence could help to clarify answers to questions regarding the role of
endocrine response in the relation between emotions and health status.
Another methodological limitation concerned the assessment of dietary nutrition. The
measure used here, a subscale of the Health Promoting Lifestyle Profile II (HPLP II),
demonstrated low internal consistency in the current sample (α = .50). This is significantly
lower than the recommended minimum .70 for internal consistency (Nunnally & Bernstein,
1994). A review of the literature revealed two previous studies using the HPLP II in
assessing health behaviors in persons living with HIV disease. One study included only
women and reported an overall scale alpha of .92, but did not report alpha for the subscales
(Riley, Lewis, Lewis, & Fava, 2008). The second study included only men and reported
subscale alphas ranging from .80 - .90; however, this sample was primarily Caucasian males.
Education attainment was similar to the current sample (53% of participants completed some
post-high school training compared to 45% in the current sample). Income may have been
higher in the previous study as the authors reported 81% of participants reported income
<$35,000 compared to 72% reporting income under <$10,000 in the current sample (Uphold,
Holmes, Reid, Findley, & Parada, 2007). Low internal consistency indicates that items on
the scale do not correlate well with the overall scale score which could mean that certain
items on the scale are not relevant to dietary habits in the current sample. Thus, findings in
regard to nutritional habits in the current sample should be interpreted with caution, and
replication of results will be necessary to confirm the relation between positive affect and
nutrition habits. Further studies should also focus on determining if the HPLP II nutrition
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subscale is an appropriate measurement tool in a population of primarily African American
males living with HIV disease.
Finally, a statistical challenge in the present study was a higher than expected
correlation between positive and negative affect that prevented meaningful tests of a
moderating hypothesis (hypothesis 5). This may have occurred as a result of adding lowactivation items to the original PANAS items, although Tugade and Fredrickson (2004) did
not comment on whether a similar effect occurred when they used the extended PANAS.
Although the correlation remained moderate when only original PANAS items were
considered, the extended low-activation PANAS items were interspersed with the original
items, and thus may have influenced responses to the original items. If future studies should
include the extended version of the PANAS, perhaps administering all of the original items
prior to the extended items would resolve this problem. Another possible explanation may
be related to measurement of emotion in persons living with HIV disease. It is possible that
the presence of a chronic stressor such as HIV infection could influence a person’s tendency
to experience both positive and negative affect. Thus, further investigation is needed to
identify an optimal means of measuring trait affect in persons living with HIV disease.
Conclusions
Overall, the current study provides some support for the use of the biobehavioral
model (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002; Williams, Barefoot, &
Schneiderman., 2003) and the broaden-and-build model of positive emotions (Fredrickson,
2000) as theoretical frameworks in studying the relations between trait affect and health
status. Specifically, the biobehavioral model was supported in that both biological and
behavioral mechanisms were found to mediate relations between trait affect and health status.
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Further, the upward spiral of positive emotion was supported in that positive affect was
associated with presence of advantageous physical and psychological resources represented
by decreased neuroendocrine response and positive health behavior practices which may
represent approach-based coping responses (Ingledew & McDonagh, 1998). The undoing
effect of positive emotions remains unevaluated in the current sample as an unexpectedly
high inverse correlation between trait positive and negative affect precluded exploration of a
moderation hypothesis.
More generally, the current results contribute to growing evidence of a possible
association between trait positive affect and decreased total cortisol concentration (Steptoe et
al., 2005) and demonstrated a mediating role for cortisol between high trait positive affect
and better immunologic status in persons living with HIV disease. The current study also
contributes new findings on the association between trait positive affect and health behavior.
Only one previously published study located has reported on an association between positive
affective style and increased physical activity, better sleep, and improved zinc intake (Cohen
et al., 2003). Current results replicate their findings with regard to physical activity and add
reduced alcohol consumption and improved general nutrition as potential correlates of trait
positive affect. Results from the current study also confirm previous findings that negative
psychological functioning is associated with poor adherence to medication (Reynolds et al.,
2004) and demonstrated that poor adherence may mediate the relation between high negative
affect and poorer virulogic and immunologic status in persons living with HIV disease. The
current results also draw attention to the possibility that health behaviors may not mediate
relations between trait affect and health status in persons with HIV. This may reflect that the
disease process puts downward pressure on this mediating relation such that immune
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dysfunction overrides any potential benefits of positive health behaviors in persons living
with HIV disease.
In summary, the current findings support the value of ongoing research investigating
the impact of trait positive and negative affect on neuroendocrine, behavioral, and health
outcomes. Future studies should seek to replicate and build upon the current findings by
utilizing longitudinal design, longer periods of cortisol assessment, and more rigorous
methods of monitoring participant adherence to salivary cortisol collection protocol.
Additional work is also needed to clarify the association between trait negative affect and
total cortisol concentration as the current study failed to support some previous findings on
this relation. Future studies could also help discern the best approach to measuring the
relation between trait positive and negative emotions and cortisol by comparing multiple
methods of assessment and by exploring the differential relations between cortisol and
discrete emotions. Continuing efforts in this line of research will contribute to a greater
understanding of the psychological, behavioral, and neuroendocrine factors that are
associated with optimal health and well-being in primarily urban-dwelling African American
persons living with HIV disease.
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Appendix A
Psychosis Screener

1. Have you ever seen or heard things that other people said were not real?
____ yes

_____ no

2. Do you have beliefs that other people see as strange (examples include thinking that other
people can read your thoughts or can insert thoughts into your mind, that people on the
television are talking to you, or that you were someone else, like the president of the US)?
_____ yes

_____ no

3. Have you ever been diagnosed with schizophrenia?
_____ yes

_____ no

4. Have you ever been prescribed an antipsychotic medication?
_____ yes

_____ no

5. If you answered yes to any of the above questions, how recently have you experienced
any of these symptoms?
_____ days ago

_____ months ago

_____ years ago
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Appendix B
Informed Consent

RESEARCH SUBJECT INFORMATION AND CONSENT FORM
TITLE: Biobehavioral mechanisms of emotion and HIV disease
VCU IRB NO.: HM10378
This consent form may contain words that you do not understand. Please ask the study staff
to explain any words that you do not clearly understand. If you wish, rather than starting the
study now you may take home an unsigned copy of this consent form to think about or
discuss with family or friends before making your decision.
PURPOSE OF THE STUDY
The aim of this project is to determine if feeling good helps patients with HIV disease to live
healthy lives. Participation is voluntary, you are free to discontinue your participation at any
time, and all responses will remain strictly confidential. Feel free to let the researcher know
if you have any questions at any time during the study.

DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT
If you decide to be in this research study, you will be asked to sign this consent form after
you have had all your questions answered and understand what will happen in the study. If
you enroll, you will be asked to give a 10 mL tube of blood during your routine medical
blood draw. Your blood may be selected as a subset of participants’ blood for further analysis
in the future. You will be asked to collect your saliva at home for 24 hours by chewing on a
special piece of cotton at five time points during a day at home. Finally, you will be
scheduled for an appointment to meet with a researcher for approximately 1 hour to complete
an interview during which you will be asked to provide information about your emotions,
behaviors, and health status. Some of these questions will be about your personal experiences
with drug and alcohol use as well as sexual behaviors. Your medical chart will also be
reviewed to determine your medical status. Your decision to participate or to not participate
in this study in no way affects your medical care, and you do not have to answer any
questions or participate in any activities you do not wish to. You may withdraw from the
study at any time, without penalty.
RISKS AND DISCOMFORTS
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You will be asked to give a 10 mL tube of blood for analysis, however, this blood will be
drawn while you are already getting blood drawn for your routine medical care. Therefore,
this study is not expected to pose any added physical risk or discomfort. Some people
become uncomfortable when asked to share their feelings and behaviors, and some may be
uncomfortable allowing researchers to access their medical records. Some may also fear that
participating in a study will increase the risk of other people learning about their diagnosis.
For this reason, your information will be kept confidential, and you will meet individually
with a researcher either in the Infectious Disease Clinic or in the General Clinical Research
Center at Virginia Commonwealth University Health Systems to complete all study
measures. Thus, the risks are no greater than those of attending your medical appointments.
Your participation in this study will in no way affect your medical treatment, and your
medical providers will not have access to information you provide as part of your
participation. If participating in this study causes you to feel upset or you become concerned
about your psychological state or your current life situation, social workers are available in
the clinic. If you desire individual therapy, the following resource is affordable and
conveniently located:


Center for Psychological Services and Development, which offers counseling services on
a sliding fee scale; 612 N. Lombardy Street, Richmond phone 828-8069.

BENEFITS
As compensation for volunteering your time, you will be given a gift card to Target in the
amount of $5, 2 GRTC bus tickets, and coupons to local restaurants and entertainment
venues. Snacks and beverages will also be available to you at your interview appointment. In
addition, as a participant in this study, you will automatically be entered into a raffle for a
$25 prize to be awarded at the completion of the study. Finally, although you may not
experience any personal benefit from participating, you will be contributing to research that
is intended to improve health and well-being for other persons living with HIV.
COSTS
There are no costs for participating in this study other than the time you will spend
completing questionnaires, collecting saliva samples, and returning to the clinic for your data
collection appointment.
CONFIDENTIALITY
Only research staff will have access to the information you give us and your physiological
data, however, information from the study and the consent form signed by you may be
looked at or copied for research or legal purposes by Virginia Commonwealth University.
Your responses, however, will never be linked to you personally, because the data from the
study will not be associated in any way with your consent form. What we learn from this
study may be presented at meetings or published in papers, but your name will not ever be
used in these presentations or papers.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
You do not have to participate in this study. If you choose to participate, you may stop at any
time without any penalty. You may also choose not to answer particular questions that are
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asked in the study if doing so makes you uncomfortable. Participating in this study in no way
affects your medical care, and withdrawing from the study will also have no affect.
QUESTIONS
In the future, you may have questions about your participation in this study. If you have any
questions, contact:
Kirk Warren Brown, PhD
Virginia Commonwealth University
808 W. Franklin Street, Room 202
P.O. Box 982018
Richmond, VA 23284
Telephone: 804-828-6754
If you have any questions about your rights as a participant in this study, you may contact:
Office for Research Subjects Protection
Virginia Commonwealth University
800 East Leigh Street, Suite 111
P.O. Box 980568
Richmond, VA 23298
Telephone: 804-828-0868
WHY IS THE STUDY INVESTIGATOR DOING THIS STUDY?
The conduct of research is an expected part of your study investigator’s professional activity
as a VCU faculty member.
CONSENT
I have been given the chance to read this consent form. I understand the information about
this study. Questions that I wanted to ask about the study have been answered. My signature
says that I am willing to participate in this study.

Subject Name (please print)
Subject Signature

Date

Name of Person Conducting Consent/Witness (please print)
Signature of Person Conducting Consent/Witness
Signature of Investigator

Date
Date
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Appendix C
Saliva Collection Instructions

You will collect saliva five times during one day at home using special cotton in plastic tubes
called salivettes. The timing of each of these samples is important because cortisol (a stress
hormone) levels change over the course of the day. It is also important that the samples are
received within three days of their collection. The researcher will discuss scheduling your
saliva collection and drop off with you when you receive the salivettes. You will find that
each salivette already has a label on it with your random data code and the time of day.
Please make sure to use each tube at the appropriate time. You will collect the first sample as
soon as you wake up, before you drink, eat, brush your teeth or smoke. Use the tube marked
“waking” for this sample. Some people find it helpful to leave the first salivette by their bed
to help them remember to do this first thing. You may then go about your normal activities,
and will collect your second sample thirty minutes after you have woken up. Use the tube
marked “30 minutes” for this sample. Then you will use the tube marked “12 noon” to collect
at 12 noon, the tube marked “5 pm” at 5pm and the tube marked “9 pm” at 9 pm. Each
sample can be collected by pulling the cotton out of the tube, placing it in your mouth and
gently sucking or chewing on the cotton for two minutes in order to thoroughly saturate the
cotton with saliva. Make sure that the cotton is very wet before placing it back into the tube.
Place all the tubes back into the bag in which you received the salivettes and bring them with
you to the clinic. A researcher will be available to receive your saliva. If the researcher is not
available when you arrive, please ask the receptionist to place your bag in the researcher box.
Please remember that the timing of the saliva samples is important, and that each time you
take a sample, you should make sure to use the tube that is marked for the time of day that
you are collecting.
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Appendix D
Demographic Form

1. What is your age?
_____ yrs
2. Sex?
Male Female
3. Are you Hispanic or Latino?
Yes

No

4. How would you describe your race?
_____ White
_____ Black or African American
_____ Asian
_____ Native Hawaiian or Other Pacific Islander
_____ American Indian or Alaska Native
_____ Other (specify)

5. Are you…
_____ Married
_____ Divorced
_____ Widowed
_____ Separated
_____ Never married
_____ Member of an unmarried couple
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6. What is the highest grade or year of school you completed?
_____ < High School diploma
_____ High School diploma
_____ Trade school/ specialized training beyond High School
_____ Some college
_____ College degree
_____ Graduate degree
7. Are you currently….
_____ employed for wages
_____ self-employed
_____ out of work for more than 1 year
_____ out of work for less than 1 year
_____ a homemaker
_____ a student
_____ retired
_____ on disability
_____ other (please describe)
8. What is your annual household income from all sources?
_____ less than $10,000
_____ $10,000-15,000
_____ $15,000-$20,000
_____ $20,000-$25,000
_____ $25,000-$30,000
_____ $30,000-$35,000
_____ $35,000-$50,000
_____ $50,000-$75,000
_____ over $75,000
9. How many persons age 18 and older live in your household?
______
10. How many persons under 18 live in your household?
______
11. How long has it been since you were diagnosed with HIV?
_____ years

_____ months
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12. How long has it been since you were infected with HIV?

_____ years

_____ months

13. How did you become infected with HIV?
_____ Sexual contact with a male
_____ Sexual contact with a female
_____ Sharing a needle
_____ Blood transfusion
_____ Other (please describe)
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Appendix E
Cortisol Log

Date: _____________
Salivette Schedule
Please collect your saliva samples in the salivettes provided to you on the following
schedule. Please try to adhere as closely as possible to the schedule. Remember to put the
piece of cotton in your mouth and suck or chew on the cotton for at least 2 minutes:
1) Immediately upon awakening (before getting out of bed, and before eating,
drinking, smoking, or brushing your teeth)
2) 30 min after awakening
3) 12 noon
4) 5 pm
5) 9 pm
Activity Log
At bedtime after collecting all of your salivettes, please complete this log on today’s
activities.
1. What time did you awaken today? ________ am / pm (circle one)
2. Hour many hours of sleep did you get last night? ________
3. Please list all food and beverages that you consumed today, including the approximate
amount
of each:
1. ______________________________
3. ______________________________
5. ______________________________
7. ______________________________
9. ______________________________

2. ______________________________
4. ______________________________
6. ______________________________
8. ______________________________
10. _____________________________
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4. If you did some form of exercise today, please indicate the activity/activities and the
duration:
Type: ___________________________
Type: ___________________________

Duration: ________ minutes
Duration: ________ minutes

5. If you consumed one or more alcoholic beverages today, please indicate how many of
each:
______ glass(es) of wine
______ beer(s)
______ drink(s) of hard liquor
6. If you smoked one or more cigarettes or cigars today, please indicate how many:
_______ cigarette(s) / cigar(s) (circle one)
7. If you experienced symptoms of a (possible) illness today, please list those symptoms:
1. _______________________________
2. _______________________________
3. _______________________________
8. If you took any medications today, please list them and the amount of each:
Medication 1: _____________________
Medication 2: _____________________
Medication 2: _____________________

Dosage: ________ mg
Dosage: ________ mg
Dosage: ________ mg

Emotions Questionnaire:
9. Use the list below the answer the following question: How happy or unhappy do you feel
today?
_____ 10. Extremely happy (feeling ecstatic, joyous, fantastic!)
_____ 9. Very happy (feeling really good, elated!)
_____ 8. Pretty happy (spirits high, feeling good.)
_____ 7. Mildly happy (feeling fairly good and somewhat cheerful.)
_____ 6. Slightly happy (just a bit above neutral.)
_____ 5. Neutral (not particularly happy or unhappy.)
_____ 4. Slightly unhappy (just a bit below neutral.)
_____ 3. Mildly unhappy (just a little low.)
_____ 2. Pretty unhappy (somewhat “blue,” spirits down.)
_____ 1. Very unhappy (utterly depressed, completely down.)
10. Consider your emotions a moment further. Today, what percent of the time did you feel
happy? What percent of the time did you feel unhappy? What percent of the time did you
feel neutral (neither happy nor unhappy)? Write down your best estimates, as well as you
can, in the spaces below. Make sure the three figures add-up to equal 100%.
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Today
The percent of time I felt happy
The percent of time I felt unhappy
The percent of time I felt neutral
Total

_____%
_____%
_____%
_____%

© Copyright Dr. Michael W. Fordyce
Women only:
9. Were you menstruating today?

Yes

No

(circle one)

10. If you used an oral contraceptive today, please indicate what type:
________________________________
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Appendix F
Extended PANAS

DIRECTIONS: This scale consists of a number of words that describe different
feelings and emotions.
Check () the box on each 5-point scale corresponding to the extent that you have
experienced each emotion during the past few weeks.
1. Interested
1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











2. Distressed

3. Excited

4. Upset

5. Strong

6. Guilty

100

7. Scared
1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











8. Hostile

9. Enthusiastic

10. Proud

11. Amused

12. Anxious

13. Calm

14. Curious

101

15. Disappointed
1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











16. Disgusted

17. Relaxed

18. Sad

19. Surprised

20. Irritable

21. Alert

22. Ashamed

23. Inspired
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24. Nervous
1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











25. Determined

26. Attentive

27. Jittery

28. Active

29. Afraid

30. Angry

31. Blue

32. Content
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33. Depressed
1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











1. Very slightly or
not at all

2. A little

3. Moderately

4. Quite a bit

5. Very Much











34. Discouraged

35. Happy

36. Relieved

37. Satisfied

38. Tired

104

Appendix G
Terry Beirn Community Programs for Clinical Research on AIDS Medication Adherence
Scale (TBCPCRA)

Section A:
To be completed by research staff with study participant.
Complete the following information with the patient for each antiretroviral drug prescribed
during any of the past 7 days. Please write in the name of the drug below. For pills that are
temporarily discontinued, record “00” for “Total # of pills per day.”
Section B:
To be completed by study participant
Many people have trouble taking all their pills all of the time. For each drug listed in Section
A, indicate how many of your pills you took during the last 7 days (check only one answer
for each drug listed). Please answer all of the questions as honestly and carefully as possible.
How you answer these questions will not affect your care or participation in this study. If
you are unsure about a question, please give the best answer you can.
SECTION A:
Drug Name # of Pills # of Doses Total # of
per dose
per day
pills/day

SECTION B:
All of
my pills
everyday

MOST
About
VERY FEW NONE
of my ONE-HALF of my pills of my pills
pills of my pills

_________ ____ X _____ = _____

_____

_____

_____

_____

_____

_________ ____ X _____ = _____

_____

_____

_____

_____

_____

_________ ____ X _____ = _____

_____

_____

_____

_____

_____

_________ ____ X _____ = _____

_____

_____

_____

_____

_____

_________ ____ X _____ = _____

_____

_____

_____

_____

_____

_________ ____ X _____ = _____

_____

_____

_____

_____

_____

_________ ____ X _____ = _____

_____

_____

_____

_____

_____
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Section C
To be completed by study participant. Do not answer these questions if you took all
your pills every day during the last 7 days for every drug listed. (Check all that apply.)
1. During the last 7 days, what part of the day did you usually MISS taking your
antiretroviral drugs?
 In the morning (upon waking until 12 noon)
 In the afternoon (between 12 noon and 5 p.m.)
 In the evening (between 5 p.m. and 9 p.m.)
 At night (9 p.m. until waking the next morning)
2. Below are some reasons why people miss taking their antiretroviral drugs. Check “Yes”
or “No” to indicate whether or not each of the following reasons describes why you usually
MISSED taking your antiretroviral drugs during the last 7 days:

a. I feel worse when I take the pills

Yes


No


b. There are too many pills to take





c. I forget to take the pills





d. I ran out of pills





e. I don’t think I need the pills





f. I was away from home





g. I did not want others to notice





h. I am too busy





i. I had problems taking the pills at specified
times (with meals, on empty stomach, etc.)





j. I was confused or uncertain about how to
take the pills





k. Other (please explain)





__________________________________
__________________________________
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Appendix H
Health Promoting Lifestyles Profile II

This questionnaire contains statements about your present way of life
or personal habits
DIRECTIONS: Please indicate how often you engage in each behavior by checking in the
box below:
1. Discuss my problems and concerns with people close to me.
1. Never

2. Sometimes

3. Often

4. Routinely









2. Choose a diet low in fat, saturated fat, and cholesterol.
1. Never

2. Sometimes

3. Often

4. Routinely









3. Report any unusual signs or symptoms to a physician or other health
professional.
1. Never

2. Sometimes

3. Often

4. Routinely









4. Follow a planned exercise program.
1. Never

2. Sometimes

3. Often

4. Routinely









1. Never

2. Sometimes

3. Often

4. Routinely









5. Get enough sleep.

6. Feel I am growing and changing in positive ways.
1. Never

2. Sometimes

3. Often

4. Routinely
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7. Praise other people easily for their achievements
1. Never

2. Sometimes

3. Often

4. Routinely









8. Limit use of sugars and foods containing sugar.
1. Never

2. Sometimes

3. Often

4. Routinely









9. Read or watch TV programs about improving health.
1. Never

2. Sometimes

3. Often

4. Routinely









10. Exercise vigorously for 20 minutes at least three times a week (such as brisk
walking, bicycling, aerobic dancing, using a stair climber).
1. Never

2. Sometimes

3. Often

4. Routinely









11. Take some time for relaxation each day
1. Never

2. Sometimes

3. Often

4. Routinely









12. Believe that my life has a purpose.
1. Never

2. Sometimes

3. Often

4. Routinely









13. Maintain meaningful and fulfilling relationships with others.
1. Never

2. Sometimes

3. Often

4. Routinely









14. Eat 6-11 servings of bread, cereal, rice, and pasta each day.
1. Never

2. Sometimes

3. Often

4. Routinely









15. Question health professionals in order to understand their instructions.
1. Never

2. Sometimes

3. Often

4. Routinely





16. Take part in light to moderate physical activity (such as sustained walking 30-40
minutes 5 or more times per week).
1. Never



2. Sometimes

3. Often

4. Routinely
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17. Accept those things in my life which I can not change.
1. Never

2. Sometimes

3. Often

4. Routinely







2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely





3. Often

4. Routinely


18. Look forward to the future.
1. Never



19. Spend time with close friends.
1. Never

2. Sometimes



20. Eat 2-4 servings of fruit each day.
1. Never

2. Sometimes





21. Get a second opinion when I question my health care provider’s advice.
1. Never

2. Sometimes

3. Often

4. Routinely





22. Take part in leisure-time (recreational) physical activities (such as swimming,
dancing, bicycling).
1. Never

2. Sometimes



23. Concentrate on pleasant thoughts at bedtime.
1. Never

2. Sometimes



24. Feel content and at peace with myself.
1. Never

2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely





3. Often

4. Routinely




25. Find it easy to show concern, love, and warmth to others.
1. Never

2. Sometimes



26. Eat 3-5 servings of vegetables each day.
1. Never

2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely




27. Discuss my health concerns with health professionals.
1. Never

2. Sometimes

3. Often




28. Do stretching exercises at least 3 times a week.
1. Never

2. Sometimes



29. Use specific methods to control my stress.




4. Routinely



3. Often

4. Routinely





1. Never

2. Sometimes

3. Often

4. Routinely
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30. Work toward long-term goals in my life.
1. Never

2. Sometimes



31. Touch and am touched by people I care about.
1. Never

2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely




32. Eat 2-3 servings of milk, yogurt, or cheese each day.
1. Never

2. Sometimes

3. Often


4. Routinely





33. Inspect my body at least monthly for physical changes/danger signs.
1. Never

2. Sometimes

3. Often

4. Routinely





34. Get exercise during usual daily activities (such as walking during lunch, using
stairs instead of elevators, parking car away from destination and walking).
1. Never

2. Sometimes



35. Balance time between work and play.
1. Never

2. Sometimes



36. Find each day interesting and challenging.
1. Never

2. Sometimes



37. Find ways to meet my needs for intimacy.
1. Never

2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely





3. Often

4. Routinely





3. Often

4. Routinely





38. Eat only 2-3 servings from the meat, poultry, fish, dried beans, eggs, and nuts
food group each day.
1. Never

2. Sometimes

3. Often

4. Routinely





39. Ask for information from health professionals about how to take good care of
myself.
1. Never

2. Sometimes



40. Check my pulse rate when exercising.
1. Never

2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely




41. Practice relaxation or meditation for 15-20 minutes daily.
1. Never

2. Sometimes



42. Am aware of what is important to me in life.



3. Often

4. Routinely





1. Never

2. Sometimes

3. Often

4. Routinely
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43. Get support from a network of caring people.
1. Never

2. Sometimes

3. Often

4. Routinely





44. Read labels to identify nutrients, fats, and sodium (salt) content in packaged
foods
1. Never

2. Sometimes

3. Often




45. Attend educational programs on personal health care.
1. Never

2. Sometimes



46. Reach my target heart rate when exercising.
1. Never

2. Sometimes



47. Pace myself to prevent tiredness.
1. Never

2. Sometimes

2. Sometimes

4. Routinely





3. Often

4. Routinely





3. Often

4. Routinely

3. Often




49. Settle conflicts with others through discussion and compromise.
1. Never


50. Eat breakfast.
1. Never


4. Routinely



2. Sometimes

3. Often

4. Routinely







2. Sometimes

3. Often

4. Routinely





3. Often

4. Routinely



51. Seek guidance or counseling when necessary.
1. Never



3. Often




48. Feel connected with some force greater than myself.
1. Never

4. Routinely

2. Sometimes




52. Expose myself to new experiences and challenges.



1. Never

2. Sometimes

3. Often

4. Routinely
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Appendix I
Alcohol Quantity Frequency Variability Measure

ALCOHOL USE: The next section asks about drinking alcohol. A drink is one 12
ounce can or bottle of beer (or wine cooler), 1 glass of wine, or 1 shot of liquor.
1. During the past 30 days, on how many days did you have at least one drink of alcohol:
_____ days/30
2. During the past 30 days, how many alcoholic drinks did you usually have in one day on
the days that you drank (remember that one drink is one 12 ounce can or bottle of beer (or
wine cooler), 1 glass of wine, or 1 shot of liquor)?
_____ average drinks in one day
3. During the last 30 days, what is the most number of alcoholic drinks you had in one day?
_____ most drinks in one day
4. Referring to your answer to question 3, on how many days did you have that “most
number of drinks” during the last 30 days?
_____ days/30
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Appendix J
Tobacco Frequency Measure

1. Have you smoked at least 100 cigarettes in your entire life? (if no, go to next section)
Yes / No
2. Do you currently smoke every day, some days, or not at all? (If not at all, skip to
question 5)
Every day / Some days / Not at all ***If some, how many days? _____
3. What kind of cigarettes do you smoke (regular, light, ultra light, menthol)?

4. How many cigarettes do you smoke on days that you smoke (a pack is 20 cigarettes)?
_____ cigarettes/day
5. If you have quit smoking, how long has it been since you quit smoking cigarettes?
_____ years _____ months
6. For how many years did you smoke cigarettes?
_____ years
7. When you smoked, how many cigarettes did you smoke per day (a pack is 20 cigarettes)?
_____ cigarettes
8. In the last 30 days, how many days have you used smokeless tobacco, or smoked pipes or
cigars?
_____ days/30
Interviewer fill in: Years smoked _______ x Packs smoked per day ________=_______
pack years.
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Appendix K
Risk Behavior Survey
A. DRUG USE:
INTERVIEWER: “I’m going to ask you some questions about your drug use. I’ll ask what
types of drugs you’ve used and how often you use them.”
1. Cocaine by itself
1a. Have you ever used Cocaine by itself (injected or snorted)?
If no use, skip to next drug, Q 2a.
No 0
Yes 1
Refused 7
Unknown 9

1b. How many days did you use Cocaine by itself in the last 30 days?
If 00, do not ask Q 1c-f, and skip to next drug, Q 2a.

__ __
1c. How many days did you inject Cocaine by itself in the last 30 days?
If 00, skip to Q 1e.

__ __
1d. How many times a day did you inject Cocaine by itself?
Average # of injections/day

__ __
1e. How many days did you use Cocaine by itself without injecting
(smoking, snorting, swallowing) in the last 30 days?
If 00, then skip to next drug, Q 2a.

__ __
1f. How many times a day did you use Cocaine by itself without injecting? __ __
2. Heroin by itself
2a. Have you ever used Heroin by itself?
If no use, skip to next drug, Q 3a.
No 0
Yes 1
Refused 7
Unknown 9

2b. How many days did you use Heroin by itself in the last 30 days?
If 00, do not ask Q 2c-f, and skip to next drug, Q 3a.

__ __ 8
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2c. How many days did you inject Heroin by itself in the last 30 days?
If 00, skip to Q 2e.

__ __ 9
2d. How many times a day did you inject Heroin by itself?
Average # of injections/day

__ __ 10
2e. How many days did you use Heroin by itself without injecting
(smoking, snorting, swallowing) in the last 30 days?
If 00, then skip to next drug, Q 3a.

__ __ 11
2f. How many times a day did you use Heroin by itself without injecting? __ __ 12
3. Heroin & Cocaine Mixed Together
3a. Have you ever used Heroin & Cocaine mixed together (speedball)?
If no use, skip to next drug, Q 4a.
No 0
Yes 1
Refused 7
Unknown 9

3b. How many days did you use Heroin & Cocaine mixed together
in the last 30 days?
If 00, do not ask Q 3c-f, and skip to next drug, Q 4a.

__ __
3c. How many days did you inject Heroin & Cocaine mixed together
in the last 30 days?
If 00, skip to Q 3e.

__ __
3d. How many times a day did you inject Heroin & Cocaine mixed
together?
Average # of injections/day

__ __
3e. How many days did you use Heroin & Cocaine mixed together
without injecting (smoking, snorting, swallowing) in the last 30 days?
If 00, then skip to next drug, Q 4a.

__ __
3f. How many times a day did you use Heroin & Cocaine mixed together
without injecting?
__ __
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4. Other Opiates
4a. Have you ever used Other Opiates (Demerol, Codeine, Dilaudid)?
If no use, skip to next drug, Q 5a.
No 0
Yes 1
Refused 7
Unknown 9

4b. How many days did you use Other Opiates in the last 30 days?
If 00, do not ask Q 4c-f, and skip to next drug, Q 5a.

__ __ 20
4c. How many days did you inject Other Opiates in the last 30 days?
If 00, skip to Q 4e.

__ __ 21
4d. How many times a day did you inject Other Opiates?
Average # of injections/day

__ __ 22
4e. How many days did you use Other Opiates without injecting
(smoking, snorting, swallowing) in the last 30 days?
If 00, then skip to next drug, Q 5a.

__ __ 23
4f. How many times a day did you use Other Opiates without injecting? __ __ 24
5. Amphetamines
5a. Have you ever used Amphetamines (Methamphetamine, Speed,
Crank)?
If no use, skip to Section B, Drug Injection.
No 0
Yes 1
Refused 7
Unknown 9

5b. How many days did you use Amphetamines in the last 30 days?
If 00, do not ask Q 5c-f, and skip to Section B, Drug Injection.

__ __
5c. How many days did you inject Amphetamines in the last 30 days?
If 00, skip to Q 5e.

__ __
5d. How many times a day did you inject Amphetamines?
Average # of injections/day

__ __
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5e. How many days did you use Amphetamines without injecting
(smoking, snorting, swallowing) in the last 30 days?
If 00, then skip to Section B, Drug Injection.

__ __
5f. How many times a day did you use Amphetamines without injecting? __ __
B. DRUG INJECTION
IF NO INJECTION USE IN PAST 30 DAYS, SKIP TO SECTION C.

1. In the last 30 days, how many times (# of injections) did you inject
using works (needle/syringes) that you know had been used by
somebody else?
If 0, then skip to B3.

__ __ __ 31
2. Of the times you injected after someone, how many times did you
clean the works with full-strength bleach?
Number cannot exceed total number of times used after another person (B1).

__ __ __ 32
3. How many times in the last 30 days did you use a cooker/cotton/rinse
water that had been used by another injector?
__ __ __ 33
4. How many times in the last 30 days did you fix drugs with another
person, then split the drug solution (through use of the same cooker/
spoon or through front or back loading)?
__ __ __ 34
C. SEXUAL ACTIVITY
INTERVIEWER: “Now I’m going to ask you some questions about sex. I’m referring here
to anybody you’ve had sex with in the last 30 days.”
1. During the last 30 days, with how many people did you have vaginal,
oral or anal sex?
IF NONE, ENTER 000 AND THE QUESTIONNAIRE IS COMPLETED.

__ __ __ 3 5
2. How many of your partners were female?
Number cannot exceed total number of people (C1).

__ __ __ 3 6
3. How many of your partners were male?
Number cannot exceed total number of people (C1).

__ __ __ 3 7
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4. INTERVIEWER: Code gender of respondent.
If Male, complete sections D, E, F, G & I.
If Female, complete sections D, G, H, & I.
If Don’t Know, ask ALL gender specific questions and allow client to answer
as they like.
Male 1
Female 2
Don’t Know 9

D. Ask MALE/FEMALE Clients who had FEMALE PARTNERS:
1a. How many women performed oral sex (“went down”) on you? __ __ __
Number cannot exceed total number of female partners (C2).
If 0, then skip to question 2a.

1b. How often did your partner(s) perform oral sex
(“go down”) on you?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
1c. How often did you use condoms/dental dams when
your partner(s) performed oral sex (“went down”)
on you?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
2a. How many women did you perform oral sex (“go down”) on? __ __ __
Number cannot exceed total number of female partners (C2).
If 0, then skip to next section appropriate for the gender of this client.
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2b. How often did you perform oral sex (“go down”) on
your partner(s)?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
2c. How often did you use condoms/dental dams when
you performed oral sex (“went down”) on your
partner(s)?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
E. Ask MALE Clients who had FEMALE PARTNERS:
1a. How many women did you have vaginal sex with?
Number cannot exceed total number of female partners (C2).
If 0, then skip to question 2a.

__ __ __ 45
1b. How often did you have vaginal sex? Once or irregularly
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
1c. How often did you use a condom?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
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1

2b. How often did you have (insertive) anal sex?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
2c. How often did you use a condom?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
2a. How many women did you have (insertive) anal sex with? __ __ __
Number cannot exceed total number of female partners (C2).
If 0, then skip to next section appropriate for the gender of this client.

F. Ask MALE Clients who had MALE PARTNERS:
1a. How many men did you have (insertive) anal sex with?
Number cannot exceed total number of male partners (C3).
If 0, then skip to next section appropriate for the gender of this client.

__ __ __ 51
1b. How often did you have (insertive) anal sex?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
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1c. How often did you use a condom?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
G. Ask MALE/FEMALE Clients who had MALE PARTNERS:
1a. How many men performed oral sex (“went down”) on you? __ __ __
Number cannot exceed total number of male partners (C3).
If 0, then skip to question 2a.

1b. How often did your partner(s) perform oral sex
(“go down”) on you?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
1c. How often did you use condoms/dental dams when
your partner(s) performed oral sex (“went down”)
on you?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
2a. How many men did you perform oral sex (“go down”) on? __ __ __
Number cannot exceed total number of male partners (C3).
If 0, then skip to next section appropriate for the gender of this client.
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2b. How often did you perform oral sex (“go down”) on
your partner(s)?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
2c. How often did you use condoms/dental dams when
you performed oral sex (went down”) on your
partner(s)?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
H. Ask FEMALE Clients who had MALE PARTNERS:
1a. How many men did you have vaginal sex with?
Number cannot exceed total number of male partners (C3).
If 0, then skip to next section appropriate for the gender of this client.

__ __ __ 60
1b. How often did you have vaginal sex?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
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1c. How often did you use a condom?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
I. Ask MALE/FEMALE Clients who had MALE PARTNERS:
1a. How many men did you have (receptive) anal sex with? __ __ __
Number cannot exceed total number of male partners (C3).
IF 0, END QUESTIONNAIRE.

1b. How often did you have (receptive) anal sex?
Once or irregularly 1
Less than once a week 2
About once a week 3
2-6 times a week 4
About once a day 5
2-3 times a day 6
4 or more times a day 7
Refused 77
Don’t know/unsure 99
1c. How often did you use a condom?
Never 0
Less than half the time 1
About half the time 2
More than half the time 3
Always 4
Don’t know/unsure 7
Refused 9
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Appendix L
Revised HIV Center Medical Staging System (rHCMSS)

Scoring Instructions: Based on history and physical examination data, but independent of CDC classification and immune status,
derive a numerical score between 0 and 39 to categorize an individual’s HIV-specific health status. First, categorize the individual
by one of the major stages: Asymptomatic, Minor Symptoms, Major Symptoms, or AIDS. Second, categorize the severity of current
symptomatology within the designated stage by assigning a score from 0-9, 10-19, 20-29, or 30-39. Note that cumulative scores are
assigned for any history or current evidence of a given symptom. ANCHORED INDICATORS ARE APPROXIMATIONS ONLY;
actual scores may include all integers and are based on clinical judgment.
1. Interview participant
2. Check medical record
Asymptomatic: Physical symptoms may be attributed to HIV infection, but are not, in themselves, of clinical
concern
0 ≈ No history of symptoms
5 ≈ Minor fatigue (less than 25 % reduction in normal activity)
9 ≈ Greater than usual upper respiratory infections
_____
10-19 Minor Symptoms: Limited, but clinically significant symptoms which are not included below (e.g. persistent
generalized lymphadenopathy, oral or vulvovaginal candida, skin and nail infections or rashes, constitutional
symptoms of limited duration, episodic diarrhea, fatigue with 25-50% reduction in normal activity, cervical dysplasia
[CIN 1-2])
10 ≈ Persistent generalized lymphadenopathy
15 ≈ ≤ 2 symptom episodes: List _____________________
19 ≈ ≥ 3 symptom episodes: List _____________________
_____
20-29 Major Symptoms: Serious physical symptoms, but not AIDS-defining conditions, including the following (check if
applicable):
_____ Oral hairy leukoplakia
_____ Night sweats > 30 days
_____ Pelvic inflammatory disease (PID)
_____ Salmonella septicemia (once)
_____ Fever > 30 days
_____ Cervical dysplasia (CIN 3)
_____ Pneumococcal bacteremia
_____ Diarrhea > 30 days
_____ Peripheral neuropathy
_____ H. influenza bacteremia
_____ Fatigue > 30 days
_____ Herpes zoster
_____ Weight loss > 10% body wt.
_____ Idiopathic thrombocytopenia purpura (ITP)
Other: ____________________________________________________________
20 ≈ ≤ 2 symptom episodes
25 ≈ Recurrent major symptom episodes
29 ≈ Chronic and/or multiple major symptom episodes
_____
30-39 AIDS: Any AIDS-indicator condition, including the following (check if applicable):
_____ Candidiasis, esophageal or pulmonary
_____ Isosporiasis, chronic intestinal
_____ Coccidioidomycosis
_____ MAC, M. kansasii or other (ds, ep)
(disseminated [ds] or extrapulmonary [ep]) _____ M. tuberculosis, any site
_____ Cryptococcosis (ep)
_____ Pneumocystis carinii pneumonia (PCP)
_____ Cryptosporidiosis, chronic intestinal
_____ Recurrent pneumonia
_____

0-9
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_____ Cytomegalovirus (not liver, spleen,
_____ Progressive multifocal leukoencephalopathy
or nodes)
_____ Encephalopathy (AIDS-related dementia)
_____ Recurrent Salmonella septicemia
_____ Histoplasmosis (ds, ep)
_____ Toxoplasmosis of brain
_____ Herpes simplex (chronic, esophagus, pulmonary)
_____ Wasting syndrome
Malignancy, SPECIFY: __ KS __lymphoma __ invasive cervical
30 ≈ ≤ 2 AIDS-indicator illness episodes and/or conditions of limited severity
35 ≈ Recurrent indicator conditions
39 ≈ Chronic and/or multiple opportunistic infections

© McCain, Lyon, Higginson, Settle, Robins, & Fisher, 1998
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Appendix M
RAND 36-Item Health Survey (RAND-36)

DIRECTIONS: Please answer each question below:
1. In general would you say your health is:
1. Excellent

2. Very good

3. Good

4. Fair

5. Poor











2. Compared to one year ago, how would you rate your health in general now?
1. Much better
now

2. Somewhat
better now

3. About the
same

4. Somewhat
worse now

5. Much worse
now











3. The following items are about activities you might do during a typical day. Does
your health now limit you in these activities? If so, how much?
a. Vigorous activities, such as running, lifting heavy objects, participating in
strenuous sports.
1. Yes, limited a lot.

2. Yes, limited a little

3. No not limited at
all







b. Moderate activities, such as moving a table, pushing a vacuum cleaner,
bowling, or playing golf?
1. Yes, limited a lot.

2. Yes, limited a little

3. No not limited at
all





2. Yes, limited a little

3. No not limited at
all






c. Lifting or carrying groceries.
1. Yes, limited a lot.
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d. Climbing several flights of stairs.
1. Yes, limited a lot.

2. Yes, limited a little


e. Climbing one flight of stairs.
1. Yes, limited a lot.

3. No not limited at
all





2. Yes, limited a little

3. No not limited at
all





2. Yes, limited a little

3. No not limited at
all





2. Yes, limited a little

3. No not limited at
all


f. Bending, kneeling or stooping.
1. Yes, limited a lot.


g. Walking more than one mile.
1. Yes, limited a lot.


h. Walking several blocks.
1. Yes, limited a lot.





2. Yes, limited a little

3. No not limited at
all





2. Yes, limited a little

3. No not limited at
all





2. Yes, limited a little

3. No not limited at
all






i. Walking one block
1. Yes, limited a lot.


j. Bathing or dressing yourself.
1. Yes, limited a lot.
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4. During the past 4 weeks, have you had any of the following problems with your
work or other regular daily activities as a result of your physical health?
a. Cut down the amount of time you spent on work or other activities?
Yes No
b. Accomplished less than you would like?
Yes No
c. Were limited in the kind of work or other activities
Yes No
d. Had difficulty performing the work or other activities (for example, it took extra
time)
Yes No

5. During the past 4 weeks, have you had any of the following problems with your
work or other regular daily activities as a result of any emotional problems (such
as feeling depressed or anxious)?
a. Cut down the amount of time you spent on work or other activities?
Yes No
b. Accomplished less than you would like
Yes No
c. Didn't do work or other activities as carefully as usual
Yes No
6. During the past 4 weeks, to what extent has your physical health or emotional
problems interfered with your normal social activities with family, friends,
neighbors, or groups?
1. Not at all

2. Slightly

3. Moderately

4. Quite a bit

5. Extremely











7. How much bodily pain have you had during the past 4 weeks?
1. Not at all

2. Slightly

3. Moderately

4. Quite a bit

5. Extremely











8. During the past 4 weeks, how much did pain interfere with your normal work
(including both work outside the home and housework)?
1. Not at all

2. Slightly

3. Moderately

4. Quite a bit

5. Extremely
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9. These questions are about how you feel and how things have been with you
during the past 4 weeks. For each question, please give the one answer that
comes closest to the way you have been feeling. How much of the time during
the past 4 weeks.
a. did you feel full of pep?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



b. have you been a very nervous person?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



c. have you felt so down in the dumps nothing could cheer you up?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



d. have you felt calm and peaceful?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



e. did you have a lot of energy?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



f. have you felt downhearted and blue?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time
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6. None of
the time



g. did you feel worn out?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



h. have you been a happy person?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



i. did you feel tired?
6. None of
the time



10. During the past 4 weeks, how much of the time has your physical health or
emotional problems interfered with your social activities (like visiting friends,
relatives, etc.)?
1. All of the
time

2. Most of the
time

3. A good
bit of the
time

4. Some of
the time

5. A little of
the time











6. None of
the time



11. How TRUE or FALSE is each of the following statements for you?
a. I seem to get sick a little easier than other people
1. Definitely true

2. Mostly True

3. Don’t know

4. Mostly false

5. Definitely false











b. I am as healthy as anybody I know
1. Definitely true

2. Mostly True

3. Don’t know

4. Mostly false

5. Definitely false











c. I expect my health to get worse
1. Definitely true

2. Mostly True

3. Don’t know

4. Mostly false

5. Definitely false











1. Definitely true

2. Mostly True

3. Don’t know

4. Mostly false

5. Definitely false











d. My health is excellent
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Appendix N
Chronic Burden

Please indicate if each of the following stressors has happened over the past month and how
much of a problem these events have been for you. (HAND SUBJECT CARD No.______)
4 = A major problem for me in the last month
3 = Somewhat of a problem for me in the last month
2 = A little bit of a problem for me in the last month
1 = Not a problem for me in the last month
Degree of Stress
1. Not having enough money to cover the basic needs of life
(food, clothing, housing)

_______

2. Not having any savings to meet problems that come up

_______

3. No reliable source of transportation (such as a car that
works of reliable bus service)

_______

4. Housing problems (uncertainty about housing, problems
with landlord, needing to find a new place to live)

_______

5. Being a caregiver for someone (taking care of someone
sick, elderly, infirmed)

_______

6. Divorce or separation from partner

_______

7. Long term, unresolved conflict with someone very
important to you (child, parents, lover/partner,
sibling, friend)

_______

8. Being fired or laid off

_______

9. Trouble with your employer (in danger of losing job,
being suspended or demoted)

_______

10. Having work hours or responsibilities change for the worse _______
11. Partner’s work hours or responsibilities change for the worse_______
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12. Serious accident, injury or new illness which happened to
you or a close family member/spouse/partner/close friend

_______

IF YES, Who was that? (RECORD RELATIONSHIP OR “SELF”)
________________
13. You or a close family member/spouse/partner, close friend
were the victim of a crime or physical assault?

_______

IF YES, Who was that? (RECORD RELATIONSHIP OR “SELF”)
_________________
14. Chronic pain or restriction of movements due to injury or
illness

_______

15. Long-term medical problems

_______

16. Having immigration or citizenship problems, either
you or someone you are close to and depend on.

_______

IF YES, Who was that? (RECORD RELATIONSHIP OR “SELF”)
__________________
17. You or close family member/spouse/partner/close friend
was arrested or sent to jail.

_______

IF YES, Who was that? (RECORD RELATIONSHIP OR “SELF”)
_________________
18. Living in a high-crime area

_______

19. Losing the help of someone you depend on (person moved,
got sick or otherwise was unavailable)

_______

20. Being discriminated against because of your race,
nationality, gender, sexual orientation, HIV status
21. Other long-term problem. Please Specify.
__________________
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_______
_______
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